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Abstract 
Phosphatidylinositol-specific phospholipase C (PI-PLC) cleaves the substrate 
phosphatidylinositol through two steps: the first step occurs in the interface between 
lipid and solution, while the second step only takes place in water soluble 
environment. For interfacial catalysis, the enzyme should bind to the lipid surface first 
before engaging its substrate, therefore interfacial kinetics include both interfacial 
binding and an interfacial catalytic step. 
The Bacillus thuringiensis PI-PLC is activated by binding to zwitterionic 
surfaces; phosphatidylcholine (PC) and two tryptophan residues (Trp47 in the 
two-turn helix B and Trp242 in a disordered loop) at the rim of the barrel structure, in 
particular, are critical for this interaction. The helix B region in PI-PLC orients the 
side chains of Ile43 and Trp47 so that they form a hydrophobic protrusion from the 
protein surface that likely facilitates initial membrane binding. An earlier crystal 
structure of the dimeric W47A/W242A mutant, which is unable to bind to PC, showed 
that the helix B region was reorganized into an extended loop. Whether this 
conformational change occurred in the wild type PI-PLC was tested with a series of 
  
iv
mutations targeting helix B residues and surrounding regions. Results strongly 
suggest that, while hydrophobic groups and presumably an intact helix B are critical 
for the initial binding of PI-PLC to membranes, disruption of helix B to allow enzyme 
dimerization is likely to play a role in the activated PI-PLC conformation. 
Besides the helix B residues, a number of hydrophobic residues along the rim of 
the αβ-barrel and close to both helix B and the active site were also altered to assess 
their contribution to membrane binding and kinetic activation. Results showed that 
Tyr86 and Tyr88, but not Tyr118, contribute to the protein binding to PC vesicles. 
These residues are capable of cation-π interactions with the choline headgroup of the 
phospholipid PC. 
Although mammalian PLCδ1 is a complex multidomain protein, the catalytic 
domain resembles the bacterial PI-PLC enzymes. Little work has been done to 
characterize the extent to which this domain contributes to membrane binding. A 
mutated protein that removes the very anionic X/Y linker region that covers the active 
site was constructed. The interfacial binding and the corresponding enzyme activity of 
this mutant against WT were measured in both micelles and large unilamellar vesicles. 
The results showed at µM protein concentration there was no large difference between 
the PLCδ1 and the deletion mutant in terms of vesicle binding. However, the deletion 
mutant showed much higher membrane binding affinity at nM concentrations. These 
results shed some light on the activation or inhibition role of the catalytic domain and 
pointed to a possible direction of future studies, for example examining specific 
mutant enzymes in the interfacial loop region.  
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Chapter 1 
Introduction 
II.  Membrane and lipids 
Biological membranes form the boundary of cells and separate the cells from 
the outside. Cell membranes have selective permeability. They contain transport 
systems that allow specific molecules to be internalized and unwanted compounds to 
be exported from the cell. The main components of these selective permeability 
barriers are lipids and proteins. The lipid bilayer forms the basic matrix of biological 
membranes and proteins are embedded in this sea of lipids.1 The dry weight ratio of 
protein to lipid ranges from 1:4 to 4:1. Carbohydrates that are covalently linked to 
lipids and proteins are also part of the membrane. Membranes play a variety of 
biological roles including 1) defining the boundaries and serving as permeability 
barriers; 2) sites of specific functions; 3) detection and transmission of chemical and 
electrical signals; 4) regulation of the transport of solutes; and 5) mediation of 
cell-to-cell communications.  
The formation of a bilayer structure by the amphiphilic lipid molecules in 
aqueous media is an energetically preferred process based on the hydrophobic effect. 
There are mainly three types of membrane lipids: cholesterol (in mammals but often 
other sterols in different eukaryotes, e.g., plants), glycolipids, and phospholipids. 
Cholesterol is a lipid based on a steroid nucleus and built from four fused 
hydrocarbon rings (Figure 1-1A). A hydroxyl group is linked to the steroid at one end, 
and a hydrocarbon tail is attached at the other end. Cholesterol is an important 
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component of mammalian cell membranes and plays essential role in regulating 
membrane permeability and fluidity. Cholesterol is also an important precursor for the 
synthesis of steroid hormones, bile acids, and fat-soluble vitamins including Vitamins 
A, D, E and K. In the mammalian cell membrane, cholesterol also functions in 
intracellular transport, cell signaling and nerve conduction.  
Figure 1-1.  Structure of cholesterol and glycolipids. 
 
Glycolipids are sugar-containing lipids that are usually derived from 
sphingosine with one or more sugars linked to the hydroxyl group of the sphingosine 
backbone (Figure 1-1B). Sugars can also be attached to a diacylglycerol backbone. 
Glycolipids always lie on the extracellular side of the plasma membrane and serve as 
markers for cellular recognition. 
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A. Phospholipids 
1.  Structure of phospholipids 
Figure 1-2. General structure and classification of phospholipids. 
 
 
Phospholipids, the major type of membrane lipids, are amphiphilic molecules 
that are composed of three components: a backbone that is in most cases glycerol, and 
two hydrophobic fatty acyl chains as well as a phosphate-containing polar or charged 
head group that are covalently linked to the glycerol backbone (Figure 1-2). 
Phospholipids are classified according to the identity of their polar head group; they 
can contain a wide variety of fatty acids serving as the hydrophobic tails. The 
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common head groups are the amino acid serine, ethanolamine, choline, glycerol, 
methanol, and the inositol. The net charge of a phospholipid depends on the head 
group and varies from 0 to -2 under physiological conditions for the lipids shown. 
Phospholipids based on backbones other than glycerol also occur. 
Sphingomyelin, which is found in animal cell membranes, for example, is generated 
from sphingosine, the common backbone for glycolipids (Figure 1-1B). In humans, 
sphingomyelin is believed to be the only cell membrane phospholipid not derived 
from glycerol. As shown in Figure 1-3, the fatty acid is linked to the sphingosine 
backbone by an amide bond and phosphorylcholine is link to the hydroxyl group of 
sphingosine by an ester bond. The functions of sphingomyelin remained unclear until 
recently, when this molecule and some of its precursors and hydrolysis products were 
found to have roles in signal transduction (particularly apoptosis)2. 
Figure 1-3. Structure of sphingomyelin. 
 
2.  Aggregation of phospholipids 
In the amphiphilic structure of membrane lipids, the two hydrophobic fatty 
acyl chains are approximately parallel to each other, while the hydrophilic head group 
points in the opposite direction. A consequence of the amphiphilic nature of the 
molecules is the formation of membrane structures by lipids. The polar head groups 
like to contact water, while the hydrophobic tails like to interact with one another, in 
5 
 
preference to water. The structure and size of the aggregates produced depend on size, 
and shape of the lipids. At the air-water interface of aqueous media, phospholipids 
always form monolayers with the heads pointing toward the water sub-phase and the 
chains toward the air. In aqueous solution, phospholipid molecules are present as 
monomers as well as aggregates with different forms present depending on the length 
and number of the fatty acid chains (Figure 1-4): a micelle is a globular structure in 
which the lipids’ head groups are surrounded by water and hydrocarbon chains kept 
inside, a vesicle is a small membrane-enclosed sack that can be visualized as a bubble 
of liquid within another liquid.  
Figure1-4. Physical states of phospholipids in aqueous solution. 
 
In general, short-chain phospholipids with chain length no longer than eight 
carbons tend to form micelles where the shape of micelles varies with the chain length, 
SUV 
LUV 
25-100nm 
100-1000nm 
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the concentration of lipid, and the surface area of the head group. Long-chain 
phospholipids form bilayer vesicles. When phospholipids are dispersed in water, they 
from multilamellar vesicles (MLV) which have more than one phospholipid bilayer 
(much like the form of an onion with multiple layers)..If a vesicle has a single bilayer 
it is called a unilamellar vesicle. Multilamellar vesicles (MLVs) formed spontaneously, 
while unilamellar vesicles require input of energy to convert them to single bilayer 
particles. 3  Small unilamellar vesicles (SUVs), with diameters in the range of 
25–50 nm, can be prepared by sonication from MLVs. Large unilamellar vesicles 
(LUVs), typically from 100 nm to 1 µm in diameter, are usually prepared by extrusion 
through polycarbonate filters (although other methods of formation exist for specific 
lipids).4  
A wide variety of factors, including hydrocarbon unsaturation, head group size, 
temperature, ionization, and hydration, can modulate the structural preferences of the 
lipid system.5 This behavior can be related to a generalized ‘shape’ property of lipid 
molecules. The dimensionless shape parameter S = v/a0lc is defined as a basic packing 
property5. Here a0 is the optimal surface area per molecule at the lipid-water interface; 
v represents the volume of the hydrophobic chains per molecule; lc is the maximum 
length of the fully extended acyl chains. The S parameters that are related to the 
corresponding molecular shapes are summarized in Table 1-1. This simple treatment 
does an excellent job of predicting particle morphology for lipids. 
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Table 1-1. Shape factor and the corresponding phase. 
 
Phase Lipid Shape Shape Factor Nomenclature 
 
Micellar 
 
S<1 Inverted Cone 
 
Bilayer 
 
 
S=1 Cylindrical 
 
Hexagonal 
 
 
S>1 Cone 
 
3.  Function of phospholipids  
Phospholipids play multiple roles in cells.6  First, as the major class of 
membrane lipids, phospholipids form the plasma membrane bilayer and intracellular 
membranes. Secondly, they work as the supporting matrix and surface for many 
catalytic processes and directly affect membrane protein structure and function. For 
example, they help some peripheral proteins anchor to the membrane. Clusters of 
particular phospholipids have been implicated as platforms for attracting proteins 
involved in diverse pathways. Thirdly, they are involved in signal transduction. For 
example, phosphatidylserine plays a role in the eukaryotic cell as an indicator of 
LL 
A0 
AH 
LL 
A0 
AH 
LL 
A0 
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apoptosis or programmed cell death 7 . Lastly, they provide precursors for 
macromolecular synthesis.  
III.  Role of peripheral membrane proteins in cells 
Peripheral membrane proteins refer to those that are only temporarily adsorbed 
on the biological membrane. These proteins attach to the peripheral regions of the 
lipid bilayer or to the integral membrane proteins embedded in the bilayer. For 
example, many regulatory subunits of ion channels or transmembrane receptors may 
be defined as peripheral membrane proteins.  
Eukaryotic cells contain a large number of distinct compartments or organelles 
separated from the bulk cytoplasm by bilayer membranes. During membrane 
trafficking, proteins form transport vesicles which then move to and fuse with the 
correct acceptor organelle. A large number of proteins are involved in these processes, 
most of which, however, are peripheral membrane proteins that are recruited directly 
from the cytosol rather than integral membrane proteins8. An explanation is that the 
peripheral protein can be recruited to the organelle where they will function directly, 
while the integral membrane protein must be initially inserted into the membrane of 
the ER and then moved through several compartments to reach the site of action. 
Moreover, if they are misrecruited, correction for the peripheral protein will be much 
easier since release from the membrane will place them back in solution. Many 
peripheral proteins play important roles in membrane trafficking, including the coat 
proteins which form vesicles, the motors that move vesicles, and the tethers which 
provide the specificity of vesicle fusion8. Several groups of proteins are involved in 
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helping peripheral membrane proteins get recruited to the membrane, including small 
GTPases such as the ARF/sar family, Rab GTPases and some lipid species such as the 
phosphoinositides, and diacylglycerol (DAG)9,10. 
Two classes of G proteins, the ARF/sar family and the Rab family, can recruit 
a large number of peripheral membrane proteins. The ARFs are divided into three 
classes. ARF1 is the most studied protein in ARF family. The ARF-GDP form shows 
only weak binding to the lipid bilayer. After being activated by GEF (guanine 
exchange factor) family, which share a Sec7 domain that is sufficient for GTP 
exchange, ARF-GTP undergoes a conformational change and can now tether other 
proteins to the bilayer. ARF1 is required for recruiting lots of proteins to Golgi 
membranes; proteins recruited include coat protein complex I (COPI) and clathrin 
coats11. For the other big family of Rab proteins, many of Rab GTPases are only 
associated with a single organelle or membrane-trafficking step. A number of effector 
proteins, which are highly organelle-specific, have been identified that are recruited 
by binding to the GTP form of Rab. Rab can be specifically activated by GEF. But 
unlike the ARF proteins, the GDP form of Rab can still be membrane-associated 
because the conformation of the membrane-anchoring part is independent of the 
nucleotide state. However the GDP form of Rab can be removed from the membrane 
by Rab GDP-dissociation inhibitor (GDI)12. 
Another major way of recruiting peripheral proteins is through the recognition 
of specific lipids. Different phosphoinositides play different roles in membrane 
trafficking. several lipid-specific targeting domains can recognize specific 
10 
 
phosphoinositides to mediate the recruitment of peripheral membrane proteins. For 
example, phosphatidylinositol (4,5)-bisphosphate (PI[4,5]P2) is now recognized as an 
important plasma membrane signal that establishes sites for vesicular trafficking, 
membrane movement and actin cytoskeletal assembly13,14. PI(4,5)P2-binding domains 
are needed for a protein to interact with PI(4,5)P2. The most characterized of 
PI(4,5)P2-binding domains is the pleckstrin homology (PH) domain15. Recently many 
other novel PI(4,5)P2-binding domains have been identified, such as Lys/Arg-rich 
PI(4,5)P2-binding domains10. After recruitment by ARF protein, phosphoinositide 
kinases and phospholipase D (PLD) promote synthesis of PI(4,5)P2 in specific 
membrane domains. In mammalian cells, PI(4,5)P2 is thought to be the beginning of 
maintaining Golgi organization and protein trafficking through the Golgi. GTPases of 
the ARF and Rho families are key regulators of phosphoinositide kinasesError! 
Bookmark not defined.. They can recruit and regulate the activity of PI(4)P 5-kinase for 
the synthesis of PI(4,5)P2 though activation of PLD, which generates PA as an 
activator of PI(4) 5-kinase. Besides phosphoinositides, other lipids such as 
diacylglycerol (DAG) and phosphatidylserine (PS) also play an important role in 
recruiting peripheral membrane proteins8.  
IV.  Phospholipases 
A phospholipase is an enzyme that catalyzes the hydrolysis of specific ester 
bonds in phospholipids to remove or modify phospholipids in the cell membrane. 
There are three major classes, phospholipase A, C and D that are distinguished by the 
site of hydrolysis they catalyze (Figure 1-5). 
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Figure 1-5. Classification of phospholipases. 
 
 
A. Phospholipase A (PLA) 
The PLA superfamily catalyzes the hydrolysis of the fatty acyl side chains of 
membrane phospholipids and has two subtypes - phospholipase A1 (PLA1) and 
phospholipase A2 (PLA2).  
PLA1 is an enzyme that hydrolyzes ester bonds of phospholipids at the sn-1 
position and generates free fatty acids (FFA) and 2-acyl-lysophospholipids. PLA1 
activities have been detected in many cells and tissues. There are nine PLA1 enzymes 
known in mammals; three are intracellular enzymes and the other six are extracellular 
enzymes.16 The intracellular and extracellular PLA1s share no sequence homologies 
and apparently have distinct functions. Some PLA1s have broad substrate scope and 
hydrolyze phospholipids, triacylglycerol (TG) and galactolipids (a subclass of 
glycolipids). By contrast, other PLA1s such as phosphatidylserine (PS)-specific PLA1 
(PS-PLA1), membrane-associated phosphatidic acid (PA)-selective PLA1α 
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(mPA-PLA1α) and mPA-PLA1β show a strict substrate specificity and act specifically 
on PS and PA.17 However, there is only limited information available about the 
structure and molecular function on PLA1 isozymes.18  
The super family of phospholipase A2 (PLA2) enzymes consists of five distinct 
types of enzymes, the secreted PLA2s (sPLA2), the cytosolic PLA2s (cPLA2), the Ca2+ 
independent PLA2s (iPLA2), the platelet-activating factor acetylhydrolases (PAF-AH), 
and the lysosomal PLA2s19. These PLA2s differ from each other in terms of substrate 
specificity, Ca2+ dependence and lipid modification. In mammalian cells, PLA2s 
hydrolyze phospholipids at the sn-2 position to generate 1-acyl-lysophospholipids and 
free fatty acids, notably arachidonic acid (AA). Both products play important roles in 
signaling pathways. For example, AA can be converted into eicosanoids through the 
action of a variety of proteins. After binding to specific G-protein coupled receptors, 
eicosanoids affect a wide range of physiological and pathological processes such as 
sleep regulation, immune responses, inflammation, and pain perception20.ref The 
lysophospholipid is a precursor to generate lipid mediators such as lysophosphatidic 
acid (LPA) or platelet activating factor (PAF). After binding to G-protein coupled 
receptors, LPA is involved in cell proliferation, survival and migration and PAF is 
specifically involved in inflammatory processes21. 
B. Phospholipase D (PLD) 
Phospholipase D, which is located in the plasma membrane, hydrolyzes the 
phosphodiester bond of the polar headgroup to generate phosphatidic acid (PA) and a 
related base. Many PLD enzymes can also carry out a transphosphatidylation reaction 
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to exchange the base esterified to PA22 . Thus, they can generate a variety of 
phosphatidyl alcohols. The PA product of PLD can be converted into lyso-PA by a 
PLA2 or converted into DAG by PA-phosphohydrolase. All known eukaryotic PLD 
superfamily members contain one or two copies of a conserved HKD motif 
(HxKxxxxD where x is any amino acid). These PLDs have four conserved regions 
(regions I–IV), and both regions II and IV contain one catalytic HKD motif. Most 
mammalian PLDs also have a Phox (PX) and a Pleckstrin (PH) homology domain, 
while plant PLDs have a C2 domain.23 PLD is present in plants, bacteria, yeast and 
mammalian cells and plays roles in signal transduction, vesicular trafficking, 
cytoskeletal rearrangements, membrane remodeling, and membrane lipid 
degradation.24   
C. Phospholipase C (PLC) 
Phospholipase C (PLC) enzymes cleave the phosphodiester bond that connects 
the glycerol backbone and phosphate to release DAG and a phosphate ester. 
Phospholipase C enzymes play a central role in signal transduction. 
Phosphatidylinositol-specific PLC (PI-PLC) enzymes exhibit substrate preferences for 
PI and its phosphorylated derivatives in the case of the mammalian systems.  
1.  Bacterial PI-PLC 
PI-PLCs have been isolated from bacteria, yeast, mold, plants, inserts and 
mammals. Of the currently characterized PI-PLCs, the bacterial PI-PLCs are secreted 
while the other enzymes are intracellular. The small bacterial PI-PLCs which can be 
produced by some pathogens, such as Bacillus cereus, B. thuringiensis, Listeria 
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monocytogenes, and Staphylococcus aureus are considered to be potential virulence 
factors25. 
Figure 1-6. Two step PI-PLC catalyzed PI hydrolysis. 
 
 
The catalytic mechanism of Bacterial PI-PLC 
PI-PLCs from B. cereus and B. thuringiensis, which are very closely related, 
have received the most attention. They have been shown to catalyze a two-step 
reaction (Figure 1-6)26. In the first step, PI-PLCs work as a phosphotransferase. They 
cleave phosphatidylinositol and produce DAG and D-myo-inositol 1,2-cyclic 
phosphate (cIP). In the second step, PI-PLCs work as a cyclic phosphodiesterase. The 
water-soluble intermediate product cIP is hydrolyzed, producing D-myo-inositol 
1-phosphate, I-1-P. The first reaction proceeds at a rate that is about 103-times faster 
than that of the second reaction, which leads to the accumulation of cIP in the reaction 
mixture. A lot of attention has been focused on the first reaction because it provides 
information about the interaction of the enzyme with the membrane lipids.  
Inositols are cyclohexanes substituted with one OH group at each carbon atom. 
The most abundant stereoisomer in nature is myo-inositol in which every hydroxyl 
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group is equatorial except for the 2-position. In PI, the phosphate is bonded to inositol 
at the 1-position. Bacterial PI-PLCs cannot hydrolyze PI molecules with phosphates 
on the 4- and 5-OH. Bacterial PI-PLCs are specific for the D-configuration of the 
esterified myo-inositol. L-myo-inositol is neither a substrate nor an inhibitor; it does 
not bind to the active site26. In contrast to this strict headgroup sensitivity, bacterial 
PI-PLCs are insensitive to the glycerol backbone or the lipid chains. All of these 
results suggest that there are multiple specific interactions between the active site 
residues and the hydroxyls of the myo-inositol, while the lipid part of the substrate 
either has little contact with the proteins or only binds to the enzyme though 
non-specific interactions. 
Glycosylphosphatidylinositol (GPI) is another important substrate for PI-PLCs. 
In GPI there is a glycosidic bonds between the 6-OH group of the PI myo-inositol and 
a linear oligosaccharide. GPI-PLC activity is not found for any of the mammalian 
PI-PLCs. GPI is a unique substrate of the bacterial PI-PLCs, and the products are 
DAG and a glycosylated polypeptide terminating in cIP. 
 Bacterial PI-PLCs have a single polypeptide chain of similar length, about 
300 amino acids. The two Bacillus PI-PLCs have very high degree of similarity - 98% 
since only eight amino acids are different. The Bacillus PI-PLC consists of a single 
globular domain which fold as a distorted (βα)8-barrel, also called a TIM-barrel. The 
TIM-barrel is a conserved protein fold consisting of eight α-helices and eight parallel 
β-strands26. The parallel β-strands form the inner wall of the barrel, whereas the 
α-helices form the outer wall of the barrel. In Bacillus PI-PLC, the TIM-barrel is 
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disrupted in region IV/V and V/VI. A loop in region V/VI and an anti-parallel strand 
in region V/VI replace the missing helices25. So the TIM-barrel structure is partially 
open in Bacillus PI-PLC. The sequence similarity of bacterial PI-PLC from different 
species is not very high. However, the secondary structures of bacterial PI-PLCs are 
very similar. The active site, which is near the surface, is between the N- and 
C-terminal halves. Crystal structures26 with or without myo-inositol show there is no 
obvious conformational change when Bacillus PI-PLC binds to the inositol portion of 
the substrate. The PI-PLC binds the inositol ring with the 2-, 3-, 4-, and 5- OH groups 
strongly coordinated with a network of hydrogen bonds. No close contact is found 
between the protein and 1- or 6-OH group of the myo-inositol ring (the latter 
interesting because the enzyme does hydrolyze GPI-anchors). There is also a planar 
stacking interaction between the apolar side of the myo-inositol ring (the face with the 
axial protons) and the phenol ring of Tyr-200.  
The catalytic mechanism is a general base and general acid mechanism, 
similar to that for ribonuclease27 (Figure 1-7 A). The two sequential reactions of 
PI-PLC are sn2 reactions. Two key histidine residues are conserved in bacterial and 
mammalian PI-PLCs. In the Bacillus enzymes, these are His32 and His82. His32 
loses its proton and forms a hydrogen bond with the 2-OH group of inositol and acts 
as a general base25. The side chain of Asp274 forms a hydrogen bond with His32 to 
help stabilize the imidazole of His32 in the correct tautomeric state for base catalysis. 
Asp274，His32, and the 2-OH group of inositol ring work together to form a catalytic 
triad and increase the nucleophilicity of oxygen for the attack on phosphorus. At the 
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same time, the protonated form of His82 begins to donate its hydrogen to the ester 
bond (Figure 1-7 B). DAG and cIP are produced from the substrate PI after collapse 
of the transition state. In the reverse reaction, which is much slower, cIP is hydrolyzed 
to I-1-P. When cIP is generated in the active site, His82 is deprotonated; it must in 
turn deprotonate water to act as the nucleophile. Protonated His32 can then supply a 
proton to generate I-1-P. The accessibility to water in the active site (to easily 
reprotonate His82) and the high Km for cIP makes this reaction slow.  
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Figure 1-7. Mechanism of bacterial PI-PLC catalyzed PI hydrolysis (A) and 
crystal structure of the B. cereus enzyme with active site residues shown and 
myo-inositol bound (B). (A) is adapted from ref (27); the structure in (B) is 
generated using Pymol. 
A 
 
 
 
B 
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Interfacial activation and inhibition of B. thuringiensis PI-PLC by PC  
PI does not dissolve in water but PI-PLC is water soluble, so this hydrolysis 
reaction takes place at the interface between lipid and solution. PI-PLC enzymes are 
modulated by interfaces in several ways. For interfacial reactions, the overall rate of 
catalytic turnover is affected not only by the kinetics of those interfacial catalytic 
steps but also by the kinetics of binding and desorption of the enzyme at the interface. 
Bacillus thuringiensis PI-PLC exhibits ‘interfacial activation,’ meaning that the 
activity is higher when PI is presented in an interface instead of as a monomer in 
solution.28  
When water-soluble cIP is used as the substrate of this cyclic phosphodiesterase, 
almost all detergents examined activate the enzyme at least 2-fold. However, 
phosphatidylcholine (PC) leads to the largest increase in cyclic phosphodiesterase 
activity29  (as show in Figure 1-8 A). The enhanced activity generated by this 
non-substrate phospholipid is thought to represent a specific binding interaction.30 
For interfacial reaction progress, the local concentration instead of bulk 
concentration is important for the overall kinetic rate. In diluting the substrate at the 
interface by adding more detergents or non-substrate lipids while keeping the total 
concentration of substrate constant, many phospholipases including PI-PLC exhibit a 
lower specific activity. This phenomenon is termed ’surface dilution inhibition‘. The 
first step of the hydrolysis PI by the bacterial PI-PLC takes place at the interface. In a 
mixed micellar system, the phosphotransferase activity of PI-PLC toward long-chain 
PI was increased with PC presentError! Bookmark not defined.2. In a vesicle assay 
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system, when the PC mole fraction is lower than 0.20, the specific activity of B. 
thuringiensis PI-PLC towards PI is significantly enhanced. As the PC mole fraction is 
increased, the activity decreases because of the surface dilution inhibition31(as show in 
Figure 1-8 B).  
These two kinetic characteristics, interfacial activation and surface dilution 
inhibition, are exhibited by many different PI-PLC enzymes. Molecular mechanisms 
may vary somewhat, but observing these features is a hallmark of phospholipases. 
  
 Figure1-8 (A) Cyclic phosphodiesterase activity of PI
inositol cyclic 1,2-monophosphate (cIP) concentration in the absence of detergent 
() or presence of () 8 mM Triton X
label is for the points connected by a solid line; the right axis label is for points 
connected by a dashed line
towards covesicles of DMPC and PI and as a function of the mole fraction 
DMPC. The PI was kept constant at 10 mM while the DMPC varied from 0 to 90 
mM. The specific activity is normalized to that for the enzyme acting on pure PI 
vesicles31.  
21 
-PLC as a function of 
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.  (B) Relative activity of B. thuringiensis
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2.  Mammalian PI-PLC 
PI-PLC isoforms (Figure 1-9) found in eukaryotes play a key role in signal 
transduction by catalyzing hydrolysis of phosphatidylinositol 4,5-biphosphate 
(PI(4,5)P2) to yield two second messengers, inositol-1,4,5-trisphosphate(IP3) and 
DAG. IP3 mediates release of intracellular Ca2+,32 and DAG can activate protein 
kinase C33. The activity of PI-PLCs also affects the concentration of PI(4,5)P2 which 
directly regulates important biological processes such as the activities of more than 20 
distinct ion channels34. Mammalian PI-PLCs and bacterial PI-PLCs have different 
substrate preferences: the mammalian PI-PLCs prefer PIP2≥PIP≥PI; while bacterial 
PI-PLCs only hydrolyze PI (and GPI, also nonphosphorylated)25.  Since the 1950’s, 
the PI-PLC enzymes have been studied because of the key role of these enzymes in 
phosphoinositide metabolism and signaling35. Since the late 1980s, cDNA sequences 
of mammalian PI-PLC isoforms have been determined36. Based on the sequence 
similarities, these isoforms were classified into five families: δ, β, γ, ε and η.  
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Figure 1--9. Domain organization and dendogram of mammalian PLC isoforms. 
A 
       
B 
         
                    (adapted from reference 34) 
 
There is a δ-like core sequence in all of the isozymes expect a sperm specific 
PLC isoform (PI-PLCζ) which plays important role in calcium mobilization required 
for fertilization. The δ-like core contains four domains: the PH domain, the EF hand 
domain, catalytic domain and the C2 domain. A unique region in PLCβ is present at 
the C-terminal end. This extension is thought to interact with regulatory proteins. The 
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sequence unique to PLCη is also located at the C-terminus. Although the domain 
organization of PLCη and PLCβ are similar, the sequence analysis shows that the 
PLCη aligns more closely to PLCδ. PLCγ has several added domains: a second PH 
domain inserted though a flexible loop into the catalytic domain, two SH2 (Src 
homology 2) regions and one SH3 (Src homology 3) region. PLCε contains one 
CDC25 domain which has a guanyl-nucleotide exchange factor activity and two RA 
(Ras association) domains that play roles in binding small GTPases from the Ras 
family. The crystal structure of PLCδ, obtained in the 1990s, was determined in two 
parts: the isolated N-terminal PH domain and the remainder of the enzyme. More 
recently a structure of PLCβ in association with Gαq has been solved36. 
The PH domain  
The PH domain was first described in the protein pleckstrin and subsequently 
reported to be present in over 100 proteins. PH domains consist of about 120 residues 
and have a remarkably conserved three-dimensional architecture despite only very 
limited sequence similarity. There are seven antiparallel β strands and a C-terminal 
α–helix arranged in a barrel-like structure. Although proteins containing PH domains 
are capable of membrane association, specificity for a particular phospholipid has 
been found only in a few PH domains. The PLCδ1-PH domain was the first observed 
one that had high-affinity for a particular lipid head-group, PI(4,5)P2 37 . In 
unstimulated cells, PLCδ1 is associated with the plasma membrane, and after 
stimulation the PH domain is dislodged from the plasma membrane38. Activated 
PLCδ1s decrease the concentration of PI(4,5)P2 and increase the concentration of the 
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IP3 to enable feedback regulation of PLCδ1 and dissociation from the plasma 
membrane. The crystal structure of PLCδ1-PH domain and IP3 show that IP3 binds the 
PH domain via a network of hydrogen bonds, involving nine amino acid residues and 
the 4- and 5-phosphate groups of IP3, and van der Waals connect between the inositol 
ring and Trp3639. The interaction between the IP3 and PLCδ1-PH domain is not 
conserved among the mammalian PI-PLC classes. Even for the PLCδ isozymes, the 
residues are not strictly conserved. Thus, the high-affinity of the PLCδ1-PH domain 
for PI(4,5)P2 may be unique. The PH domain from PLCγ1 has been reported to show 
high affinity for PI(3,4,5)P340. However, many of the PH domains of the PLC 
subfamily do not have a high-affinity for PI(4,5)P2 or PI(3,4,5)P3 and instead bind a 
zwitterionic phospholipid, phosphatidylcholine (PC), tightly41.  
The EF-hand domain 
The EF-hand domain contains of four helix-loop-helix motifs and forms a 
flexible tether between PH domain and the rest of the enzyme. Like the PH domain, 
the EF-hand domain also has a remarkably conserved three-dimensional architecture 
despite only very limited sequence similarity. In PLCs, the first two motifs appear to 
be much more flexible than the last two and are only partially visible in the crystal 
structures of the catalytic core of PLCδ1. The last two motifs make interactions with 
the C-terminal domain of PLCδ1. Although there are some residues that would be 
required for calcium binding in the first two motifs, there is no evidence that the 
PLCδ1 domain does indeed bind calcium ions. A long, well-ordered linker sequence 
connects the EF-hand domain to the catalytic domain.  
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The catalytic domain 
 The catalytic domain of PLCδ1 consists of a distorted TIM barrel with very 
similar secondary structure to the bacterial PLCs. The mammalian PLCs and bacterial 
PLCs have similar catalytic residues, notably the two catalytic histidines, providing 
evidence of an evolutionary relationship between the enzymes. The residues which 
form the two halves of the barrel are connected by insertion of a linker sequence. The 
sequences of the two halves are usually called as the X and Y region. The X region 
shows the greatest sequence conservation among the mammalian PLCs42. Because of 
the salt bridge between the 4- and 5-phosphoryl groups and the basic residues in the 
active site, the substrate preference of the mammalian PI-PLCs is PI(4,5)P2 > PI(4)P 
or PI. The mammalian PLCs catalyze the cleavage of PI(4,5)P2 via a two-step 
mechanism similar to that for the bacterial enzymes but with the help of a Ca2+ 
cofactor. There is a direct interaction between the Ca2+ cofactor and 2-OH of the 
substrate (Figure 1-10). The role of the cofactor is to lower the pKa of the 2-OH and 
aid in the nucleophilic attack on the 1-phosphate and to neutralize the negative charge 
developed in the transition state of the reaction. The Ca2+ cofactor is also proposed to 
make a direct interaction with the transition state and the intermediate of the reaction, 
which may explain why the mammalian enzyme tends to retain the cyclic phosphate 
intermediate in the active site and complete the second step of the reaction to generate 
the acyclic product43. Residues His311 and His356 in PLCδ1 have been considered 
for the role of His32 and His82 in the bacterial PI-PLC. Besides the two general 
acid/base catalytic residues, Glu341 and Glu390 not only bind the calcium but also 
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form hydrogen bonds with the 2-OH group of the inositol (Figure 1-10 B) and are 
thought to help the proton transfer of the 2-OH group.  
The C2 domain  
 The C-terminal domain of PLCδ1 is present in all of the isozymes and consists of 
an eight-stranded anti-parallel β-stand. These domains have high sequence similarity 
and are similar to the second conserved domain from protein kinase C, the so called 
C2 domain. The C2 domain is a calcium-dependent phospholipid binding domain, and 
the crystal structure of the PLCδ1 shows three Ca2+ binding sites in this domain44. 
This suggests that the C2 domain may be involved in membrane binding, perhaps 
through Ca2+ binding to PS45. 
Mechanism of bacterial PI-PLC catalyzed PI hydrolysis (A) and crystal structure of 
the B. cereus enzyme with active site residues shown and myo-inositol bound (B). A 
are adapted from ref (27); the structure in B is generated using Pymol. 
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Figure 1-10. (A) Mechanism of mammalian PLC catalyzed PI hydrolysis. (B) 
Crystal structure of mammalian PLCδ1 active site showing substrate and 
cofactor Ca2+ interactions with the protein. (A) is adapted from ref (27); the 
structure in (B) is generated using Pymol. 
 
A 
 
 
 
Ca2+
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V. Thesis directions 
The aim of this dissertation is to understand on a molecular level the activation 
mechanism of B. thuringiensis PI-PLC, and the kinetic activation and inhibition 
mechanism of the catalytic domain of the multiple-domain peripheral membrane 
protein, rat PLCδ1.  
The first part of my project was to investigate the mechanism by which the 
catalytic activity of B. thuringiensis PI-PLC is activated by binding to surfaces. 
Previous studies from the group have underlined the importance of Trp47 in helix B. 
Removal of this residue reduced activation by phosphatidylcholine (PC) and also 
reduced the affinity of the protein for PC interfaces.46 Later on, the crystal structure 
of an interfacially impaired B. thuringiensis PI-PLC, the W47A/W242A mutant, was 
solved and shown to be a dimer.47 In this structure, a dramatic conformational change 
of the protein was observed: helix B no longer exists and these residues adopt a loop 
conformation. In order to explore what conformation of the protein can stabilize the 
membrane activation, a series of mutations of helix B residues were constructed and 
characterized. In these studies, CD was used for detecting any changes in protein 
secondary structure, NMR was used for analyzing PC activation of PI cleavage and 
cIP hydrolysis, and fluorescence was used to probe the affinity of the altered proteins 
for different interfaces. Although there was no direct evidence for the dimer form of 
the wild type protein as the conformation upon membrane binding, my studies 
suggested this could occur.  
Besides the helix B residues, a number of hydrophobic residues along the rim of 
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the αβ-barrel and close to both helix B and the active site were also altered to assess 
their contribution to membrane binding and kinetic activation. My studies clearly 
show that several of these residues do contribute to the protein binding to 
phospholipid vesicles. Tyr86 and Tyr88, but not Tyr118, contribute to the protein 
binding to PC vesicles. These residues are capable of cation-π interactions with the 
choline headgroup of the activating phosholipid PC. 
The second part of my project focused on the studies of mammalian PLCδ1. 
Although previous studies have revealed the important role of PH domain and C2 
domain in the membrane binding of the enzyme45, there has not been much research 
focused on how the catalytic domain contributes to membrane binding. Studies of the 
B. thuringiensis PI-PLC as a model, however, pointed to the fact that rim residues in 
the catalytic domain should play some role in membrane activation and interaction. In 
my studies of the rat PLCδ1, the X/Y linker region – which covers the active site and 
is full of negatively charge residues – was removed from the protein. The interfacial 
binding and the corresponding enzyme activity of this mutant against WT were 
measured in both micelles and large unilamellar vesicles (LUVs). The mutant protein 
had much higher activity than WT in most assay systems. In order to monitor the 
binding in multi-component LUVs, fluorescence resonance energy transfer (FRET) 
using moderate protein concentrations and fluorescence correlation spectroscopy 
(FCS) using nM protein were used. At µM protein concentration there was no large 
difference between the PLCδ1 and the deletion mutant in terms of vesicle binding. 
However, the deletion mutant showed much higher membrane binding affinity at nM 
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concentrations. These results shed some light on the activation or inhibition role of the 
catalytic domain and pointed to a possible direction of future studies, for example 
examining specific mutant enzymes in the interfacial loop region. 
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Chapter 2 
Materials and Methods 
I.   Materials 
A.   Phospholipids 
Most of the lipid powders or solutions in organic solvent were purchased from 
Avanti Polar lipids, Inc., and used without further purification. These include the 
synthetic short-chain phospholipid diheptanoylphosphatidylcholine (diC7PC) and 
long-chain phospholipids 1-palmitoyl-2-oleoyl-phosphatidic acid (POPA), 
1-palmitoyl-2-oleoyl-phosphatidylserine (POPS), L-α-phosphatidylinositol (PI) from 
bovine liver, 1,2-dioleoyl-sn-glycero-3-phosphatidylmethanol (DOPMe),  
1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) and 1-palmitoyl-2-oleoyl- 
phosphatidylglycerol (POPG). Crude PI from Sigma Chemical Inc. was used for the 
enzymatic generation of cIP by PI-PLC1. 
B.  Resins 
Q Sepharose Fast Flow and Glutathione Sepharose 4B were purchased from 
GE Healthcare. Phenyl Sepharose CL-4B was purchased from Sigma Chemical Inc. 
C.  Other chemicals 
Restriction enzymes and T4 DNA ligase were purchased from New 
England BioLabs. Most other chemicals, such as isopropanol (iPrOH), chloroform, 
ethanol, D2O, Tris, HEPES, glycerol and Triton X-100, were purchased from Sigma. 
All competent cells used in mutagenesis (Super blue) and overexpression (BL21 
Codonplus) were obtained from Stratagene. 
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II Methods 
A  Molecular biology techniques 
1.  Cloning and site-directed mutagenesis 
 
Figure 2-1 Plasmid map of the B. thuringiensis PI-PLC gene inserted into the 
pHN 1403 vector. The map shows the PI-PLC coding region, the promoter and 
other important features of the vector (adapted from Jianwen Feng, Ph.D. thesis, 
Chemistry Department, Boston College, 2004). 
 
 
 
A plasmid containing the wild type B. thuringiensis PI-PLC gene was obtained 
as a gift from Dr Ming-Daw Tsai at Ohio State University. The plasmid map is shown 
in Figure 2-1. The plasmid containing the wild type mammalian (rat) PLC δ1 gene 
was a gift from Dr. Matilda Katan at the Cancer Research UK Centre for Cell and 
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Molecular Biology, Chester Beatty Laboratories, the Institute of Cancer Research, 
London, U.K. The plasmid map of this gene is shown in Figure 2-2. 
Figure 2-2  Plasmid map of mammalian PI-PLCδ1 gene inserting into the 
PGEX-2T vector. The map shows the PI-PLC coding region and other important 
features of the vector. 
 
 
All B. thuringiensis PI-PLC mutants were constructed using the 
Quik-ChangeTM Site-Directed Mutagenesis Kit. We also used the Quik-ChangeTM 
Site-Directed Mutagenesis Kit to delete 11 amino acids in the X-Y linker loop of the 
mammalian PI-PLC. An overview of the QuikChange site-direct mutagenesis method 
is shown in Figure 2-3. Primer design followed the instruction manual with the 
following constraints. (a) Both primers must have the desired mutation. (b) Primer 
length should be between 25 and 45 bases, and the desired mutation (deletion) should 
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be in the middle. (c) The melting temperature (Tm) should be over 78 oC. (d) The 
primer needs to be at least 40% GC. The HPLC purified mutagenic primers were 
purchased from Operon. The identities of the mutations in the altered genes were 
confirmed by sequencing performed by GENEWIZ. Several double mutants or triple 
mutants were made by introducing additional mutations in the gene coding for a 
single mutant or double mutants. The list of mutagenic primers is show in Table 2-1. 
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Figure 2-3. QuikChange site-directed mutagenesis method. The annealing 
temperature was set as 68°C for B. thuringiensis PI-PLC. 
                      
 
  
Step 1 
Plasmid Preparation 
 
 
 
 
 
 
 
Step 2 
Temperature Cycling 
For B. thuringiensis PI-PLC: 
Denaturation (95ºC for 30 s) 
Annealing (68ºC for 1 min) 
Extension (68ºC for 12 min) 
For mammalian PI-PLCδ1: 
Denaturation (95ºC for 30 s) 
Annealing (68ºC for 1 min) 
Extension (68ºC for 15 min) 
12-18 cycles 
 
 
 
 
 
 
Step 3 
Digestion 
 
 
 
 
 
 
 
Step 4 
Transformation 
 
 
 
Gene in plasmid with target site 
for mutation. 
 
 
 
 
 
Denature the plasmid and 
anneal the oligonucleotide 
primer containing the desired 
mutations 
 
 
 
 
Using the Pfu Turbo DNA 
polymerase, extend and 
incorporate the mutagenic 
primers resulting in nicked 
circular strands/ 
 
 
Digest the methylated, 
nonmutated parental DNA 
template with DpnI 
 
 
 
 
 
Transform the circular, nicked 
ds DNA into XL1-Blue 
supercompetent cells 
 
After transformation, the 
XL1-Blue cells repair the nicks 
in the mutated plasmid 
Target site 
Mutagenic 
primers 
Mutated 
palsmid 
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Table 2-1. List of mutagenic primers corresponding to site specific mutagenesis 
of PI-PLC. 
Mutant Complimentary Mutagenic Primers (from 5’ to 3’) 
B. thuringiensis PI-PLC 
L39A TAGTGGGACGTTCAAG-GCG-CAAAATCCGATTAAGC 
GCTTAATCGGATTTTG-CGC-CTTGAACGTCCCACTA 
V46A AATCCGATTAAGCAA-GCG-TGGGGAATGACGCAAG 
CTTGCGTCATTCCCCA-CGC-TTGCTTAATCGGATT 
G48A CGATTAAGCAAGTGTGG-GCA-ATGACGCAAGAATATG  
CATATTCTTGCGTCAT-TGC-CCACACTTGCTTAATCG 
K44E TTGCAAAATCCGATT-GAG-CAAGTGTGGGGAATGACGC 
GCGTCATTCCCCACACTTG-CTC-AATCGGATTTTGCAA 
P42G GGGACGTTCAAGTTGCAAAAT-GGG-ATTAAGCAAGTGTG
GGG 
CCCCACACTTGCTTAAT-CCC-ATTTTGCAACTTGAACGTC
CC 
Q45A GCAAAATCCGATTAAG-GCA-GTGTGGGGAATGACGC 
GCGTCATTCCCCACAC-TGC-CTTAATCGGATTTTGC 
Y88A CATCATGGGCCATTA-GCT-CTTTACGTAACACTG 
CAGTGTTACGTAAAG-AGC-TAATGGCCCATGATG 
L85A TCTTCATCATGGGCCA-GCA-TATCTTTACGTAACACTGC 
GCAGTGTTACGTAAAGATA-TGC-TGGCCCATGATGAAGA 
L85C CTTCATCATGGGCCA-TGC-TATCTTTACGTAACACTGC 
GCAGTGTTACGTAAAGATA-GCA-TGGCCCATGATGAAG 
Y86A CATCATGGGCCATTA-GCT-CTTTACGTAACACTG 
CAGTGTTACGTAAAG-AGC-TAATGGCCCATGATG 
Y88A GCCATTATATCTT-GCC-GTAACACTGCATG 
CATGCAGTGTTAC-GGC-AAGATATAATGGC 
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Y86AY88
A 
CATCATGGGCCATTA-GCT-CTTGCCGTAACACTG 
CAGTGTTACGGCAAG-AGC-TAATGGCCCATGATG 
Y88C GCCATTATATCTT-TGC-GTAACACTGCATG 
CATGCAGTGTTAC-GCA-AAGATATAATGGC 
Y88W GCCATTATATCTT-TGG-GTAACACTGCATG 
CATGCAGTGTTAC-CCA-AAGATATAATGGC 
H81A ATACGATAGTTCTT-GCT-CATGGGCCATTATATC 
GATATAATGGCCCATG-AGC-AAGAACTATCGTAT 
Rat PI-PLCδ1 
D11 GCCACTGACGTGTCT-GCTGTGCGCAGCCAA 
TTGGCTGCGCACAGC-AGACACGTCAGTGGC 
H311 CTTAGTGTCTTCTTCC-GCC-AACACCTACCTGCTGG 
CCAGCAGGTAGGTGTT-GGC-GGAAGAAGACACTAAG 
H356A GAACCCATCATCTAC-GCC-GGCTACACTTTTACC 
GGTAAAAGTGTAGCC-GGC-GTAGATGATGGGTTC 
 
 
2. 2 Over-expression 
 The plasmid was transformed into E. coli BL21-Codonplus (DE3)-RIL cells 
by the heat-shock method. A clone was picked and incubated overnight in 5 ml LB 
media containing 34 µg/ml chloroamphenicol and 100 µg/ml ampicillin. Then the 5 
ml LB media was added to 2 L LB media with the same concentrate of antibiotics and 
incubated at 37 oC. When the OD600 reached 0.8, IPTG was added to a final 
concentration of 0.6 mM; the cell suspension was then incubated at 16 oC. After 16-20 
hours, the cells were harvested by centrifugation at 5000 rpm for 15 min; the cell 
pellets were frozen at -20oC. Using this protocol, both PI-PLC and rat PLCδ1 have 
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been expressed previously. 
The cell pellets of B. thuringiensis PLC were dissolved in Tris buffer (20 mM 
Tris HCl, pH 8.0) and the cell pellets of mammalian PI-PLCδ1 were dissolved in PBS 
buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8mM KH2PO4, pH 7.3). 
The cells were lysed by sonication on ice (30 s pulses at moderate powere repeated 10 
times). After centrifugation (13,000 rpm, 30 min), the supernatant with enzyme was 
collected for purification steps.  
3. .  Purification 
(a)  B. thuringiensis PI-PLC 
The protocol for purification of recombinant PI-PLC follows previously 
published methods in the laboratory 1 . Supernatant with enzyme was dialyzed 
overnight against 20 mM Tris HCl, pH 8.0, at 4 oC. A Q-sepharose fast flow column 
(1.5 cm x 12 cm) was equilibrated with Tris buffer (Tris HCl, pH 8.0). The 
supernatant containing the protein was loaded onto the QFF column at a rate of 2 
ml/min. The enzyme was eluted with a NaCl gradient ranging from 0 to 0.6 M in the 
Tris buffer at rate of 2 ml/min. The enzyme was checked using SDS-PAGE and was 
further purified use a phenyl-sepharose column. After adjusting the NaCl 
concentration to 0.6 M, we loaded the enzyme onto the phenyl-sepharose column (1 
cm x 10 cm) at rate of 1 ml/min. The enzyme was eluted with a decreasing NaCl 
gradient ranging from 0.6 M to 0 mM in Tris buffer at rate of 1 ml/min. The purity of 
PI-PLC enzymes was above 95% as monitored by SDS-PAGE (see Figure 2-4). 
Protein solutions were concentrated using Millipore Centraplus 10 filters; 
44 
 
concentrations were determined by Lowry assays2.  
(b)  Mammalian PI-PLCδ1 
Purification of the GST-tagged mammalian PI-PLC followed procedures 
developed by the Katan laboratory 3 . The supernatant containing enzyme was 
incubated overnight with glutathione Sepharose 4B (2 ml) in PBS buffer (pH 7.3). 
The column with enzyme was washed three times with PBS buffer, and then 
incubated with thrombin (50 unit). Eluted protein was concentrated using Millipore 
Centraplus 10 filters. Concentrations were determined by UV using calculated molar 
extinction coefficients. The purity of mPLC enzyme was above 85% as monitored by 
SDS-PAGE (example shown in Figure 2-4).  
Figure 2-4. SDS-PAGE of purified B. thuringiensis PI-PLC (btPLC) and rat 
PLCδ1 and the XY-linker deletion mutant protein (∆11). 
 
               
 
4.  Modification of PI-PLC 
(a) Covalent dimer formation 
Several mutants of B. thuringiensis PI-PLC were made to introduce a single 
cysteine at different positions for spin-labeling the protein4. This bacterial PI-PLC has 
Marker   btPLC     PLCδ1           ∆11   marker 
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no cysteine normally. In the absence of dithiothreitol (DTT), B. thuringiensis PI-PLC 
Cys mutants (Y88C, L85C), stored at a high concentration (~10 mg/ml), formed some 
disulfide-linked homodimers as monitored by non-reducing SDS-PAGE. The yield 
was over 90% dimers after one week. These covalent dimers were fairly stable and 
could be stored up to 20 days prior to use without loss of activity (measured after 
adding DTT). Protein monomers were generated and maintained in solution by the 
storage of the PI-PLC solutions with 5 mM DTT or by adding 5 mM DTT 20 min 
before use in kinetics or binding studies. 
(b) PI-PLC site-directed spin labeling 
B. thuringiensis PI-PLC Cys mutants Y88C and L85C were specifically spin 
labeled on the Cys with 1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl- 
methanethiosulfonate (MTSL). The reaction scheme is shown below: 
 MTSL, obtained from Toronto Research Chemicals Inc., was prepared as a 10 
mg/ml stock solution in acetone and stored in the freezer. The purified PI-PLC 
variants (concentrated to 20 mg/ml in 20 mM Tris, pH 8.0) were first incubated with 5 
mM DTT for 20 min at room temperature or overnight at 4 oC for full reduction of 
any intermolecular disulfide bonds, monitored by non-reducing SDS-PAGE. DTT was 
then removed by two Micro Bio-spin 6 columns (up to 75 µl solution could be loaded 
on each spin column). The protein was then diluted to 5 mg/ml in 20 mM Tris, pH 7.5, 
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and 3-fold DTT was added to make sure all the Cys were reduced to free sulfhydryls. 
Then a 10-fold MTSL over total –SH was then added and the resulting solution 
incubated for 1 h at room temperature, followed by overnight incubation at 4 °C. The 
excess spin label reagent was removed by three successive Micro Bio-Spin 6 columns. 
The labeling percentage was > 95%, monitored by non-reducing SDS-PAGE.  
(c) PI-PLC specific N-terminal labeling with Alexa Fluor 488 
Mammalian PLCδ1 enzymes (WT and ∆11) were specifically labeled on the 
N-terminal amino group with the succinimidyl ester of the Alexa Fluor 488 carboxylic 
acid according to the manufacturer's protocol. The AF488 dye was prepared as a 5 
mg/ml (7.8 mM) stock solution in anhydrous DMSO and stored at -20 °C. The protein 
concentration in the reaction was in the range of 5-20 mg/ml (concentrations lower 
than 2 mg/ml are said to greatly decrease the efficiency of the reaction). Critical to the 
labeling protocol is to ensure that the solutions is free of any amine-containing 
substances such as Tris, glycine, ammonium ions, or stabilizing proteins such as 
bovine serum albumin. This reagent reacts with non-protonated aliphatic amine 
groups, including the N-terminus of the protein and the ε-amino group of lysines. The 
ε-amino group has a pKa ~10.5, while the N-terminal amino group has a lower pKa, 
typically around 8.5-9. To preferentially label the N-terminal amine, the reaction is 
done in a buffer with a slightly basic pH. Prior to labeling, 1 µL of 2 M sodium 
phosphate buffer (pH 8.5) was added for each 50 µL solution of protein. A 2-fold 
molar excess of AF488 dye was added to the protein and the solution incubated on ice 
for 20 min to 1 hour. The AF488 labeled protein was separated from free AF488 
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using three Bio-Spin 6 columns. Less than 50 µL sample was loaded onto each spin 
column for efficient separation. All variants had a labeling ratio of 90±20%, 
determined by comparing the absorption of the protein at 280 nm to that of the probe 
at 495 nm. The equation used for calculating the labeling ratio was: [Dye]/[P] = 
(92665 cm-1M-1/71000 cm-1M-1) x A495/(A280-0.11A495); where 92665 cm-1M-1 is the 
extinction coefficient of PLCδ1 at 280 nm, 71000 cm-1 M-1 is the extinction 
coefficient of AF488 at 495 nm and 0.11 A495 is the correction for the absorbance of 
the dye at 280 nm.  
(d) PI-PLC specific N-terminal labeling with NBD 
Mammalian PI-PLCδ1 proteins (WT and ∆11) were also specifically labeled 
on the N-terminal amino gorup with the succinimidyl 6-(N-(7-nitrobenz-2-oxa-1,3- 
diazol-4-yl)amino)hexanoate (NBD-X, succinimidyl ester) according to the 
manufacturer's protocol (described above for Alexa labeling. The NBD dye was 
prepared as a 25 mg/ml (32 mM) stock solution in anhydrous DMSO and stored at 
-20 °C. A 1-fold molar excess of NBD-X dye was added to the protein and the 
solution incubated on ice for 20-40 min. The NBD-X labeled protein was separated 
from free NBD-X using three Bio-Spin 6 columns. All variants had a labeling ratio of 
90±20%, determined by comparing the absorption of the protein at 280 nm to that of 
the probe at 465 nm. The equation used for calculating the labeling ratio was: 
[Dye]/[P] = (92665 cm-1M-1/24000 cm-1M-1) x A465/(A280-0.072A465); where 92665 
cm-1M-1 is the extinction coefficient of PI-PLCδ1 at 280 nm, 24000 cm-1M-1 is the 
extinction coefficient of NBD-X at 465 nm and 0.072 A465 is the correction for the 
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absorbance of the dye at 280 nm.  
D.   Spectroscopic techniques 
1.  CD spectroscopy 
Circular Dichroism (CD) is the differential absorption of left- and right- circularly 
polarized light. Electromagnetic radiation is plane polarized when the electric and 
magnetic fields each oscillate in a single plane. Circular polarization occurs when the 
electric and magnetic fields rotate around the direction of propagation in either a 
clockwise or a counterclockwise sense but still remain perpendicular to each other. 
When circularly polarized light passes through a sample, the absorption between right 
and left polarizations can differ. CD spectroscopy can determine secondary structure 
in the far-UV spectral region (190-250 nm). In the far-UV region the peptide bond is 
the main chromophore, and the signal changes when it is located in different chiral 
environments. α-helix, β-sheet, and random coil structures each give a characteristic 
CD spectrum. The CD signal reflects an average of the entire protein secondary 
structure. Analyzing the far-UV CD spectrum as a linear combination of the different 
secondary structure motifs provides us with the approximate fraction of each 
secondary structure type in the protein. CD spectroscopy can also be used to monitor 
the thermal denaturation of proteins5.  
Recombinant PI-PLC secondary structure was measured using an AVIV 202 CD 
spectrophotometer (Figure 2-5). Comparison of secondary structure for recombinant 
wild type and mutant B. thuringiensis PI-PLC used wavelength scans from 195 to 300 
nm with protein (0.3–0.4 mg/ml) in a 0.1 cm cell at 25 °C; the program CDNN678  
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Figure 2-5. (A) CD spectrum of WT PI-PLC (0.4 mg/ml) in 10 mM borate pH 8.0. 
(B) Temperature dependence of CD signal of B. thuringiensis PI-PLC at 222 nm 
(adapted from Jianwen Feng, Ph.D. thesis, Chemistry Department, Boston 
College, 2004) 
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was used to estimate fractions of secondary structure. The Tm, or temperature for loss 
of 50% of the secondary structure, can be used to assess overall folding of proteins. In 
the case of PI-PLC the transition is irreversible. Tm for PI-PLC was monitored at 222 
nm (which is dominated by α-helix) by increasing the temperature from 25 to 90 oC 
(1o per min); the protein, 0.03–0.04 mg/ml, was contained in a 1 cm cell. 
2.  NMR spectroscopy 
(a) 31P NMR spectroscopy 
The specific activity of PI-PLC mutants was measured by monitoring cIP or 
I-1-P generation using 31P NMR (202.3 MHz) spectra obtained on a Varian INOVA 
500. NMR parameters were based on those previously reported9,10. Phosphorylated 
product formation for either fixed time points or continuous assays was analyzed11. 
For B. thuringiensis PLC, the buffer was 50 mM HEPES, pH 7.5, 1 mM EDTA, and 
for PLCδ1, the buffer was 50 mM HEPES, pH 7.5, 0.5 mM Ca2+ and 100 mM NaCl. 
The amount of enzyme added in each kinetic run (50 ng to 3 µg depending on 
whether the phosphotransferase or the cyclic phosphodiesterase was monitored, 
respectively) was adjusted to generate less than 20% product within the desired 
reaction time. PI cleavage and cIP hydrolysis rates were measured from the integrated 
intensity of cIP and I-1-P resonances (in the absence of 1H decoupling), respectively, 
as a function of incubation time, using the 31P resonance of glucose-6-phosphate or 
KH2PO4 of known concentrations (2 or 4 mM) as an internal reference (Figure 2-6). 
The PI concentration was 5, 6 or 8 mM; diC7PC was usually 24 or 32 mM but was 
also increased for surface dilution studies. The assay temperature for B. thuringiensis 
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PLC was 22 oC and 37 oC for PLCδ1. The hydrolysis of cIP (20 mM) was monitored 
in the absence or presence of 5 or 8 mM diC7PC. For PI-PLC activity toward PI 
presented in small unilamellar vesicles (prepared by sonication), the PI concentration 
was 8 mM with 2 mM POPC. 
Figure 2-6.  NMR spectra for the activity assays of (A) the bacterial PI-PLC 
phosphotransferase reaction, (B) the bacterial PI-PLC cyclic phosphodiesterase 
reaction, and (C) the mammalian PLCδ1 reaction (at a fixed time point). 
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(b) High resolution field cycling 31P NMR (fc-P-NMR) 
High resolution field cycling 31P NMR (fc-P-NMR) experiments were run at 
Brandeis University using a unique system devised by Prof. Alfred G. Redfield.25 The 
basic experiment is to measure the spin-lattice relaxation rate, R1 = 1/T1, over a wide 
range of magnetic fields. For my studies, R1 experiments were obtained at 25oC on a 
Varian Unityplus 500 spectrometer using a standard 10-mm Varian probe in a 
custom-built device that moves the sample between the probe and a higher position 
within, or just above, the magnet, where the magnetic field is between 0.06 and 11.7 T 
12
. To access lower fields (0.005 up to 0.07 T), the sample was shuttled to a region 
outside and above the magnet and into the middle of an extra coil, where the current 
was adjusted to the desired field13. The samples for field cycling were sealed in a 10 
mm tube with a minimum amount of head space to avoid bubble formation as the tube 
is rapidly shuttled up and down the magnetic bore. Experiments to cover a field range 
of 0.005 up to 11.7 T typically took a span of 24-36 h. 
 The fc-P-NMR technique to measure relaxation rates is extremely useful for 31P 
nuclei (in particular phospholipids in different aggregates but also for small 
phosphorylated molecules). At the high fields of modern spectrometers, the bulk of 
the 31P relaxation is caused by chemical shift anisotropy (CSA). Dynamics in 
molecules are best assessed through dipolar relaxation, and for phospholipids in 
vesicles, field strengths of less than 2 Tesla (T) are needed to have relaxation rates 
dominated by dipolar interactions. For comparison, the field of a 500 MHz 
spectrometer is 11.7 T. Sensitivity and resolution are provided by the high field 
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spectrometer – chemical shifts for different head group phospholipids are nicely 
resolved – but interpretation of R1 values is nearly impossible. fc-P-NMR allows us to 
measure R1 over a very large range and then use standard NMR theory to describe the 
relaxation as a function of field strength. There are three easily observed dispersions 
at different time scales (each characterized by a correlation time τ) in these field 
dependence profiles:  (i) a 50-300 ps dispersion (above 2 T) that dominates high 
field R1 and is from CSA and fast motions of nonspherical electron clouds around the 
31P (not very useful for exploring protein/ligand binding dynamics), (ii) a 5-20 ns 
dipolar dispersion around 0.08-1 T that has been proposed to reflect phospholipid 
wobble motion, and (iii) a 1 µs or so dipolar dispersion only observed at very low 
fields (below 0.02 T) that has contributions from vesicle tumbling and lateral 
diffusion of phospholipids in the bilayer leaflet. Extracting dynamic parameters for 
phospholipids in vesicles in each of these regions has been described in detail12. 
However, for my work, the correlation times and maximum extrapolated relaxation 
rates in each region are of minor importance. I introduce a spin-label at a specific site 
on the B. thuringiensis PI-PLC and then look at how the very large electron dipole 
perturbs 31P nuclear relaxation in the very low field region. The difference in R1 
profiles for a vesicle sample with unmodified and spin-labeled protein provides a 
direct measure of the paramagnetic relaxation enhancement for the 31P. The larger this 
is, the closer the phospholipid is to the spin-label site on the protein. Also, if an effect 
is seen in this region it means a discrete complex must exist where the 
spin-label/phospholipid orientation is maintained for at least 1 µs but less than 1 ms 
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(otherwise the bound phospholipid is in slow exchange and not detectable in the high 
resolution experiment because its concentration is so low). More details on how an 
averaged distance between a 31P of a phospholipid and the electron on the spin-label 
attached to the protein is obtained are provided in Chapter 4. 
3.  Fluorescence spectroscopy 
The electrons in molecules of certain compounds are excited by a beam of 
light. Return of the system back to the ground electronic state can occur with the 
emission of light of a lower energy. The emission or fluorescence can be used to 
monitor environmental and conformational changes of macromolecules by looking for 
changes in maximum emission wavelength or altered emission intensity14.  
(a) Intrinsic fluorescence of PI-PLC 
Fluorescence measurements of B. thuringiensis PI-PLC (2 µM) were carried 
out on Fluorolog R-3 spectrofluorometers. The excitation wavelength was 282 nm (to 
ectie Trp and Tyr residues). Changes in the fluorescence intensity at 337 nm (the 
emission maximum and characteristic of Trp emission) upon the addition of lipids 
(either diC7PC or POPC SUVs) were expressed as (I-Io)/Io, where Io is the emission 
intensity of protein alone, and I is the intensity in the presence of an additive. An 
apparent binding constant to POPC vesicles was obtained by fitting the change in 
intensity with a hyperbolic function to extract a bulk concentration of PC for half the 
maximum change.  
(b) Fluorescence resonance energy transfer (FRET) 
FRET is a distance-dependent interaction whereby one chromophore can 
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transfer energy to another. First, the donor chromophore absorbs light to the electronic 
excited state. The excited donor chromophore then transfers its energy to an acceptor 
chromophore though nonradiative dipole-dipole coupling (Figure 2-7). For efficient 
FRET, the distance between donor and acceptor should be close, although the range 
of distances sensed varies with the FRET pair of chromophores (10-100 Å). There 
must be overlap of the emission spectrum of the donor with the absorption spectrum 
of the acceptor. For most efficient FRET, the donor and acceptor transition dipole 
orientations should be approximately parallel. The interaction of PLCδ1 with the 
membrane was evaluated using NBD-labeled mammalian PLCδ1 serving as donors 
and rhodamine-labeled lipids as energy acceptors (Figure 2-5). A solution of 
NBD-PLCδ1 (donor) in 20 mM Tris, pH 7.5, with 100 mM NaCl and 1 mg/ml BSA, 
was prepared. Then SUVs with a few % rhodamine-labeled lipid (acceptor) were 
added to the protein solution in several sequential doses. The mixture was incubated 
for 2 min at 25 oC, and the fluorescence spectra were obtained before and after adding 
the acceptor. The excitation monochromator was set at 465 nm with a 2 mm slit width 
and the fluorescence emission was measured at 535 nm with a slit width of 5 nm. The 
percent of energy transfer (E) was determined by measuring the decrease in the 
quantum yield of the donor (NBD-PLCδ1) as a result of the presence of the acceptor 
(rhodamine-labeled lipids). The % FRET was determined experimentally by the ratio 
of the fluorescence intensities of the donor (NBD-PLCδ1) in the presence (Fda) and 
absence (Fd) of the acceptor (rhodamine-labeled lipids), at the donor’s maximum 
emission wavelength (535 nm). Monitoring the donor emission is usually easier than 
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the acceptor emission, since the acceptor can be quenched by other interactions when 
bound to the protein. The extent of FRET is given by  
%FRET = (1- Fda/Fd) x 100 
 
Figure 2-7 Excitation (dashed line) and emission spectra of NBD (green) and 
rhodamine (blue).  
 
 
(c) Fluorescence Correlation Spectroscopy (FCS).  
FCS is an experimental technique which uses statistical analysis of the 
fluctuations of fluorescence in a system in order to decipher dynamic molecular 
events, such as diffusion or conformational fluctuations of biomolecules. We used 
FCS to analyze the binding of fluorescently labeled mammalian PLCδ1 to lipid 
vesicles. FCS experiments were performed using a home-built confocal setup (in the 
Gershenson laboratory at the University of Massachusetts, Amherst) based on an 
IX-70 inverted microscope (Olympus) as shown in Figure 2-815.  
Briefly, the 488 nm line of an air-cooled argon-krypton laser was used to 
excite the sample, and a 500 drlp dichroic mirror reflected the laser light into a 60X 
water objective mounted on the inverted microscope. The same dichroic passed the 
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fluorescence emission, and any remaining scattered laser light was blocked by a filter. 
A 30 µm confocal pinhole was used to define the observation volume and to block out 
of focus fluorescence. The fluorescence was collimated, split by a non-polarizing 
50-50 beam splitter and focused onto two photodiodes. For AF488 labeled protein, 
HQ535/50 bandpass filters before the focusing lenses blocked the Raman scattering. 
Rhodamine-labeled SUVs were excited using the 520 nm laser line with a change in 
all the different filters. The photon counts from the photodiodes were collected by a 
2-channel data acquisition card, and associated software was used to calculate and 
analyze the auto- and cross-correlations (ISS). 
FCS experiments were carried out at 22 °C on 300 µL samples in phosphate 
buffered saline (PBS), pH 7.3, plus 1 mg/ml bovine serum albumin, to stabilize 
PI-PLC. The samples were placed in chambered coverglass wells (LabTek). Prior to 
use, the chambers were coated with 10 mg/ml bovine serum albumin for 10 min and 
rinsed with PBS buffer to prevent PLCδ1 protein adhesion on the sides of the wells. 
For PLCδ1 vesicle binding experiments, 8 nM labeled protein was titrated with 
unlabeled vesicles. The substrate, PI was not used for FCS experiments because PI 
cleavage by PI-PLC produces DAG leading to vesicle fusion16. Thus, the anionic 
phospholipids DOPMe, POPG, DOPA and DOPS were used as substrate analogues.  
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Figure 2-8 FCS experimental schematic. Individual laser lines from an air-cooled 
argon-krypton, multi-line laser are separated using a quartz prism, P. The 488 
nm laser line is picked off, expanded 5 times using two lenses, L1 & L2, in order 
to overfill the back aperture of the microscope objective and reflected into the 
sample using a 500drlp dichroic, D1. In the IX-70 inverted microscope, the 60X 
water objective, Obj, with a numerical aperture of 1.2 focuses the laser light into 
the sample and collects the emission. The emission passes through D1 and any 
remaining scattered laser light is blocked by a HQ505lp long pass filter, F1. The 
emission is then focused onto a 30 μm pinhole by the lens, L3, in the microscope 
to limit the detection region and collimated by lens L4. To calculate the 
cross-correlation, the fluorescence signal is spilt by a 50-50 beam splitter D2, and 
passed through a HQ535/50 bandpass filter, F2, F3 and focused on two 
avalanche photodiodes, APD1, APD2, by lenses L5 and L6, respectively. The 
rhodammine-labeled LUVs were excited using the 520 nm laser line with a 
535drlp dichroic mirror (D1) and HQ450lp longpass filter (F1) in the microscope, 
and the filters in front of the photodiodes (F2 & F3) were replaced by HQ645/75 
bandpass filters (Chroma Technology). (Adapted from Mingming Pu, Ph.D. 
thesis, Chemistry Department, Boston College, (2009)). 
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Chapter 3 
Role of Helix B Residues in Phosphatidylcholine Activation of a 
Bacterial PI-PLC 
I. Introduction 
The Bacillus thuringiensis phosphatidylinositol-specific phospholipase C 
(PI-PLC) exhibits a very specific interfacial activation towards monomer and 
aggregated substrates upon binding to phosphatidylcholine interfaces.1 Although the 
(βα)8-barrel core of closely related PI-PLC appears relatively rigid, hydrophobic 
regions at the rim of the barrel in helix B (Ile43-Gly48) and the 237-244 loop have 
significant mobility as measured by B factors.2 Previous work has clearly pointed to 
the importance of Trp47 and Trp242 in binding to activating PC interfaces (and at 
least one of them crucial for the protein to bind to anionic phospholipids surfaces).3 
The rim Trp residues appear to be part of a binding site for PC molecules.4 Removal 
of either Trp reduces activation by PC; removal of both renders the enzyme incapable 
of binding to PC interfaces.3a Indeed, for the rim loop interfacial mutants of PI-PLC 
examined thus far (shown are Trp242 alterations), the specific activity (in both 
phosphotransferase and cyclic phosphodiesterase assay systems) correlates with how 
tightly the PI-PLC binds to activating PC SUVs (Figure 3-1). However, helix B 
mutations do not follow this trend. Introduction of a tryptophan at other positions in 
helix B in the PI-PLC mutant W47A generated proteins that could bind well to PC 
vesicles but usually were much less active than wild type PI-PLC.3c. 
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Figure 3-1. Correlation of apparent Kd, which measures the partitioning of 
PI-PLC and mutants to POPC SUVs, with enzymatic activity toward (A) 8 mM 
PI solubilized in 24 mM diC7PC or towards (B) 5 mM cIP with 5 mM diC7PC 
added. Squares represent W242A (in the rim loop) and rescue mutants, the open 
triangle is wild type PI-PLC, and the filled circles are helix B W47A and rescue 
mutants (data from reference (3c)). 
 
 Furthermore, the single helix B mutant that regained significant kinetic activation 
by PC compared to W47A, I43W/W47A, did not bind tightly to PC vesicles.3c 
I43W/W47A has a tryptophan on the same side of the two-turn helix B as Trp47. The 
lower activity of I43W/W47A as well as the other helix B mutants, which bind PC 
well but are relatively inactive,3c suggest most of the mutations cannot retain the 
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unusual conformation that is critical for interfacial activity. 
Recently, the crystal structure of the W47A/W242A mutant was solved.5 This 
interfacially impaired PI-PLC is a dimer in contrast to the highly homologous B. 
cereus PI-PLC, which crystallizes as a monomer.2 The dimer interface has a 
hydrophobic core of tyrosine residues that are quite removed from the active site.5 In 
the dimer, residues Ile43 to Gly48 no longer form a helix but instead adopt an 
irregular loop with an increased distance between residues 43 and 46 (Figure 3-2). In 
the B. cereus PI-PLC, helix B has the Ile43, Val46 and Trp47 side chains packed 
together to form a plug extending into solution. Such a hydrophobic plug could aid in 
initiating and stabilizing membrane binding. In the W47A/W242A double mutant, the 
Ile43 side chain is reoriented towards the protein core. If attachment of the plug is a 
part of the initial binding of the protein to a PC interface, then mutations that 
destabilize the helix in solution would be expected to reduce PC affinity and lead to 
lower PC activation of cIP hydrolysis. However, there are interactions of residues in 
and around helix B (e.g., Pro42 and Gln45) that appear to stabilize the dimer interface, 
and these cannot be accommodated with a helical structure for this segment of the 
protein.5 To explore in more depth the contribution of helix B residues to enzyme 
activity and phospholipid aggregate binding, I systematically altered individual 
residues in helix B (an a few neighboring residues) to Ala. The original idea was to 
see if we could find support for the existence of a dimeric protein similar to that seen 
in the W47A/W242A crystal structure.34 
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Figure 3-2 Local structure of helix B in (A) B. cereus PI-PLC and (B) a monomer 
of B. thuringiensis W47A/W242A PI-PLC. (C-F) Surface representations 
showing the location of helix B residues (Leu39 blue, Pro42 orange, Ile43 blue, 
Lys44 orange, Gln45 magenta, Val46 pink, Trp47 blue, and Gly48 green), and 
their relation to active site residues (His32, Arg69, and His82 colored in red) in B. 
cereus PI-PLC (C, D) and B. thuringiensis W47A/W242A (E, F). For each 
enzyme the left and right side panels represent ‘front’ and ‘back’ (rotated by 
180o) views of the helix B, active site, and dimerization interface regions of the 
protein.  
 
II. Study of Helix B by mutagenesis 
In order to explore what is needed to stabilize the ‘membrane active’ 
conformation of the protein, a series of PI-PLC mutants of helix B residues (as well as 
regions around this structural feature) were constructed and characterized. Alanine 
mutants of each position in helix B (43-48) as well as Leu39 were constructed and 
characterized for any changes in secondary structure (CD spectroscopy), PC 
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activation of PI cleavage and cIP hydrolysis, and the ability to bind to PC interfaces 
(comparing both protein intrinsic fluorescence in the presence of PC vesicles and a 
vesicle filtration assay). The mutant that replaces Lys44, the only charged residue in 
helix B, with an anionic group (Glu) was also examined. Pro42, the residue 
immediately before the start of helix B, was altered to P42G, replacing a 
conformationally restricted residue with a very flexible one.  
All these mutants except K44A exhibited lower activity for one or both steps 
of PI hydrolysis under standard assay conditions. However, there were differences 
among the mutants that allow us to propose a mechanism for PI-PLC activation by PC 
and to assess the formation of a membrane-induced dimer as a key step for optimal 
activity. The results are consistent with (i) formation of helix B in solution to prevent 
dimerization of the protein in solution, (ii) initiation of binding to PC membranes by 
the hydrophobic helix B ‘plug’, and (iii) possible disruption of helix B once the 
protein is anchored in preparation for either dimer formation with another membrane 
bound PI-PLC to generate the ‘membrane active’ form of PI-PLC or interaction of the 
surface Tyr occluded by the plug with PC headgroups enhancing protein binding to 
interfaces.  
A. Secondary structure of helix B alanine mutants 
In the crystal structure of monomeric wild type B. cereus PI-PLC,2 helix B 
points the hydrophobic side chains of Trp47 and Ile43 out into solution. In the 
structure of the interfacially impaired dimeric B. thuringiensis W47A/W242A,5 helix 
B no longer exists – rather the residues adopt a loop that is closer to the rim loop that 
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normally contains Trp242. Pro42 contributes to dimer formation through hydrophobic 
interactions with both Tyr247 and Tyr248 of the opposite chain. Gln45 participates in 
a hydrogen bond with Gly239 of the opposite chain. Since the dimer is observed in an 
interfacially impaired mutant and residues in the helix B region appear to stabilize the 
dimer, there are two key questions: (i) is the membrane active structure of this PI-PLC 
a dimer, and (ii) is helix B intact when the protein binds to interfaces. Recent 
mutagenesis of a cluster of tyrosines that form the hydrophobic core of the dimer 
interface are consistent with a dimeric structure of PI-PLC for optimum activity 
(although participation of the Tyr in π-cation interactions with PC molecules can not 
be excluded).6 To assess the contribution of helix B to activity and binding of 
activator phospholipids, we have constructed alanine mutants at each position in helix 
B as well as at Leu39 and introduced a Gly in place of Pro42, the residue that forms a 
cap over helix B. All mutants overexpressed well in E. coli and had similar CD 
spectra and Tm (as monitored by loss of negative ellipticity at 222 nm)3a as wild type 
recombinant PI-PLC indicating that they were well-folded with the same overall 
structure. I43A, K44A, W47A had the same secondary structure as PI-PLC. However, 
L39A, P42G, Q45A, V46A, and G48A exhibited a reduced α-helix content (as much 
as 3% loss compared to the wild type recombinant protein in solution) in low ionic 
strength buffers when compared by CD (Figure 3-3). For all of these but Q45A, the 
addition of 2 mM diC7PC caused the protein to regain α-helix structure to different 
degrees. These results illustrate a structural maleability in this region of the protein 
when it is in solution and several of the residues are altered. 
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Figure 3-3. Difference in α-helix content for each mutant compared to 
recombinant PI-PLC: protein (~ 0.4 mg/ml in 10 mM borate buffer, pH 8.0, in 1 
mm cuvette) in the absence (5) and presence (///) of 2 mM diC7PC. For 
comparison, the secondary structure of the native protein from CD appears to be 
25.5% α-helix, 24.4% β-sheet, 17.8% β-turn, and 32.3 % random.3b 
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B. Mutant phosphotransferase and cyclic phosphodiesterase activities 
A comparison of the cIP hydrolysis rates in the absence and presence of 
diC7PC is shown in Figure 3-4A for these helix B mutants. In the absence of any 
interfaces, all the mutants had cIP cleavage rates were 58 to 96% of recombinant 
PI-PLC enzyme activity (except for L39A and Q45A which exhibited 10% and 39%). 
Thus, monomer activity was more or less unaltered in this series of mutants. Addition 
of diC7PC micelles increased all activities with the activation-fold (ratio of the 
activity plus PC compared to that in its absence) comparable to native protein for 
L39A, I43A and K44A; V46A was reasonably activated as well although not quite to 
the same extent (Figure 3-4B). P42G, Q45A, W47A and G48A were all much less 
sensitive to kinetic activation by this nonsubstrate phospholipid suggesting either a 
reduction in diC7PC affinity or an altered binding of the protein to these micelles.  
While the cyclic phosphodiesterase rates were very sensitive to modification 
of helix B residues, the phosphotransferase activities only varied at most three-fold 
(Figure 3-4C). Poor PC activation of cIP hydrolysis did not necessarily imply poor 
phosphotransferase activity (e.g., P42G and G48A show the opposite behavior). 
Conversely, for some enzymes with high cIP activation, phosphotransferase activity 
could be low (L39A, I43A).  
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Figure 3-4 Activities of PI-PLC helix B mutants with Ala or Gly (for P42G) 
substituted at the position indicated. (A) Specific activity for cleavage of20 mM 
cIP in the absence (5) and presence (///) of 8 mM diC7PC. (B) DiC7PC activation 
presented as the ratio of cIP hydrolysis activity in the presence or absence of 
diC7PC. (C) Specific activity for cleavage of PI (8 mM) solubilized in 32 mM 
diC7PC. Errors in specific activities were less than 15% of the indicated values. 
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C. Binding of mutants to PC SUVs 
 Recombinant PI-PLC bound moderately tightly to POPC SUVs with an apparent 
Kd = 0.067±0.015 mM. 3b Of these helix B region mutants, only K44A and G48A 
exhibited affinities for PC SUVs comparable to the native PI-PLC protein (Figure 
3-5). Cationic Lys44 does not insert into membranes and the structural change from 
Gly to Ala would not alter the Kd for G48A significantly even if this group were 
positioned in a membrane. L39A and W47A had the weakest affinity for PC, with 
apparent Kd values roughly 50-70-fold more than that of native PI-PLC. The 
estimated Kd values for each mutant in Figure 3-5 is based on free energy differences 
for side chains in membranes from the Wimley-White scale.7 The increased apparent 
Kd for W47A is clearly consistent with the indole ring partitioning into the membrane. 
However, the apparent Kd for the Leu39 substitution is far greater than expected 
solely on the basis of membrane partitioning. Although the Leu side chain could 
localize in the membrane, it is likely that substitution at this position alters the protein 
conformation and disposition of other residues involved in membrane partitioning 
(possibly Trp47). Alanine substitutions at the other positions in helix B exhibited a 
6-12-fold loss of affinity for PC. Here, the loss of binding affinity does not correlate 
with changing the identity of a group that inserts into the membrane. Rather, these 
residues must be involved in other interactions that modulate PC binding.  
 In the crystal structure of B. cereus PI-PLC,2 helix B side chains do not interact 
significantly with the rest of the protein (Figure 3-2, C and D). If helix B remains 
intact and acts as a hydrophobic plug for interface binding, only the removal of 
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residues poised on the hydrophobic helix face, Ile43, Val46 and Trp47, should reduce 
membrane binding. However, in the W47A/W242A dimer, both Pro42 and Gln45 
make intersubunit contacts (Figure 3-2, E and F). Therefore, the significantly 
weakened affinities of P42G and Q45A (compared to native PI-PLC) for PC could 
reflect impaired dimerization on the membrane surface. Reduced dimerization could 
weaken the binding of the enzyme to the PC surface by increasing the off rate of the 
protein. 
 
Figure 3-5 Apparent dissociation constants for helix B region mutants binding to 
POPC SUVs in 10 mM Tris HCl, pH 7.5. The binding was monitored by both 
changes in the intrinsic Trp fluorescence as a function of added POPC SUVs as 
well as a filtration/centrifugation binding asssay. The Kd in the hatched bars for 
the nonpolar side chains is what would be predicted for the Kd if that particular 
residue partitioned into the bilayer. The apparent Kd for native PI-PLC is 
0.06±0.02 mM. 
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D. Positional mutants and charge reversal mutants of helix B 
If a helical hydrophobic plug (residues Ile43-Gly48) is needed for initial 
interaction of PI-PLC with PC, it should be stabilized by hydrophobic residues facing 
outwards on the same side of helix B. Indeed, this is consistent with the observation 
that only I43W/W47A and no other Trp rescue mutant, could significantly recover the 
PC interfacial activation of cIP hydrolysis lost in W47A.3c However, full PI cleavage 
activity was not observed with I43W/W47A, nor was it observed in I43A (Figure 
3-4C). This might suggest a specific positional arrangement of hydrophobic residues 
is critical in the helix B region of the protein.  
Two additional mutants were examined to check for the importance of where 
the helix B Trp was placed. The swap mutant I43W/W47I should be equivalent to 
native PI-PLC kinetically and structurally if the position of Trp on helix B matters less 
than its orientation in solution and its stabilization by another hydrophobic side chain. 
I43W, which maintains the critical Trp47 residue in helix B3a was made to see if the 
addition of a larger hydrophobic side chain had any effect on PI-PLC kinetic behavior. 
Both proteins had comparable secondary structure and similar phosphotransferase and 
cyclic phosphodiesterase specific activities (Table 3-1) to native PI-PLC. Specific 
activities were also determined for cleavage of PI solubilized in 30% iPrOH, PI in 
Triton X-100 micelles, and PI in vesicles with 20 mol% PC as well as for the 
PI/diC7PC mixed micelle system (Table 3-1).  
The swap mutant had similar activity to native PI-PLC in all but the iPrOH 
assay system.8 I43W was not quite as active as native PI-PLC with the additional Trp 
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residue in this region. Nonetheless, these results suggest that the position of the Trp in 
the helix B region is less important that its packing with another hydrophobic residue 
(presumably to stabilize helix B in solution). 
The swap mutant also had about the same affinity for POPC SUVs as native 
protein (Table 3-2). I43A, where the Ile that stabilizes outward facing Trp47 in 
PI-PLC has been removed, had a weakened affinity for PC vesicles that correlates 
with its reduced phosphotransferase and PC activation of cIP hydrolysis rates. 
Changing Ile to Trp (I43W) enhanced enzyme partitioning to SUVs, but not enough to 
imply that both Trp in helix B are inserted into the PC membrane (the predicted Kd if 
both Trp insert would be 0.005 mM versus the experimental value of 0.026 mM). 
Since the specific activities for this mutant were always lower than native PI-PLC, it 
is possible that packing two Trp together in that helix is either difficult or makes the 
helix a bit more hydrophobic and alters its orientation. 
We also examined in greater detail changes at residue 44. Lys44 represents the 
only charged residue in the helix B region. Replacement of the cationic side chain by 
a methyl group had no significant effect on enzyme activity in assay systems with 5 
mM substrate in either diC7PC micelles or in a water-iPrOH cosolvent or PI/PC 
vesicles.3b Specific phosphotransferase activity was only reduced with PI dispersed in 
Triton X-100. If Lys44 does contribute significantly to enzyme binding to 
substrate-containing PI/PC, we must be sufficiently above the apparent Kd such that 
there is little effect on the specific activity with the assay conditions used. 
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Table 3-1 Relative phosphotransferase (towards PI in different assay systems) 
and cyclic phosphodiesterase (cIP as substrate) activities of rPI-PLC and selected 
helix B mutants.a 
Substrate 
(mM) 
PI cIP 
(5) (5) (5) (8) (5) c Activation d
 
Assay system 
30% 
iPrOH 
PI/diC7PC 
(1:4) 
PI/TX100 
(1:2) 
PI/POPC 
(4:1) 
SUVs 
diC7PC 
(5 mM) 
+diC7PC 
-diC7PC 
WT 0.72 b 1.00 0.67 b 0.017 0.19 46 
I43A 0.32 0.36 0.31 0.006 0.15 36 
I43W/W47A 0.13 b 0.54 b 0.42 b 0.008 0.056 47 
I43W/W47I 0.39 0.90 0.60 0.016 0.09 33 
I43W 0.45 0.82 0.54 0.014 0.11 55 
K44A 0.68 0.98 0.36 0.018 0.16 33 
K44E  0.44   0.024 4.5 
 
a
 All specific activities, except for K44E, were obtained at 22oC, and are referenced to 
cleavage of 5 mM PI solubilized in 20 mM diC7PC (955 µmol min-1 mg-1 at 22oC). 
Values are averages of fixed time point assays done in duplicate; errors were < 15% 
of the indicated value.  
b  From Feng et al. (2002).3a 
c  Values for cIP in the absence of activating PC were lower than reported 
previously,3a,c which were obtained at a higher temperature (28 versus 22 oC). The 
value for native PI-PLC under these conditions was 2.8 µmol min-1 mg-1. The ratio 
shown is for hydrolysis of 5 mM cIP in the presence of 5 mM diC7PC. 
d
 The extent of PC activation of the enzyme for cIP hydrolysis was estimated by 
comparing specific activity in the presence of diC7PC to the activity towards cIP 
alone. 
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However, replacing Lys44 with an anionic residue (Glu) reverses the net 
charge on helix B, and leads to an enzyme, K44E, with both reduced PI cleavage and 
cIP hydrolysis in the presence of activating PC (Table 3-1) and reduced affinity for 
POPC vesicles (Table 3-2). Introduction of a negative charge at this position weakens 
binding of the enzyme to PC interfaces. The recombinant K44E also had an unusual 
CD spectrum in that it had 7.4% less α-helix than native PI-PLC, suggesting less 
stable helical conformations in solution. However, the addition of 2 mM diC7PC led 
to an increase in α-helix at the expense of β-sheet and random coil (similar to what 
was observed for P42G). The selective loss of PC activation with the charge reversal 
of the lone charged group in helix B could suggest that it may be very close to a PC 
binding site, possibly near the phosphate rather than the trimethylammonium moiety. 
Alternatively, it may indicate that changing the charge on helix B will repel it from 
any negatively charged lipids and this reduces both specific activities and also affects 
the ability of PC to bind and act synergistically with substrate to anchor the enzyme. 
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Table 3-2 Apparent binding constants for recombinant PI-PLC and selected 
helix B mutants interacting with PC aggregates. 
 
a  K0.5 is estimated as the bulk concentration of diC7PC that leads to 50% of the 
maximum change in fluorescence intensity upon binding to that short-chain PC; the 
value for WT PI-PLC is the average of three separate experiments. 
b  K0.5-CMC is the value extracted for 50% of the fluorescence increase if only data 
above the CMC is used and fit with a hyperbolic function that reflects micellar 
diC7PC only. Micellar PC is calculated as the concentration of diC7PC minus the 
CMC (1.5mM). 
c  Extracted from data presented in (3a). 
d
 Extracted from Feng et al.3c  
e
 Estimated by using the increase in intrinsic florescence of the protein when it binds 
to PC vesicles.9 
Previous work suggested that Trp242 is the main fluorophore responsible for 
the increased intrinsic fluorescence intensity when PI-PLC binds to PC activator 
micelles.3a This can be exploited to compare the affinities of the different helix B 
mutants for diC7PC micelles. As an example (shown in Figure 3-6A), the change in 
fluorescence intensity of native PI-PLC upon diC7PC micelle formation increased at 
lower diC7PC concentrations than that of I43A, consistent with the weaker binding of 
I43A to POPC surfaces. The slight lag in the fluorescence change for I43A suggests 
more PC molecules are needed to drive micelles binding. 
PI-PLC 
app Kd (mM) calc. Kd (mM) K0.5 (mM)a K0.5-CMC (mM)b 
POPC SUVs  diC7PC micelles 
native 0.067±0.010  1.86±0.08 0.36±0.06 
I43A 0.37±0.07 0.15 2.28±0.10 0.75±0.06 
I43W/W47A 0.85±0.17d 0.15 2.48±0.39d 1.08±0.33d 
I43W/W47I 0.064±0.008 0.067 1.67±0.07 0.18±0.07 
I43W 0.026±0.06 0.005 1.65±0.07 0.17±0.09 
K44A 0.087±0.01  1.59±0.07 0.08±0.04 
K44E 0.50±0.20 e    
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Figure 3-6 Increase in fluorescence intensities of B. thuringiensis PI-PLC 
proteins (WT (), I43A (), I43W (), I43W/W47I (▲), K44A (X)) at 337 nm as 
a function of diC7PC (A) total diC7PC concentration and (B) micellar diC7PC. 
 
The mutants I43W/W47I and I43W exhibited fluorescence behavior 
comparable to native PI-PLC/ The K0.5 values, which represent total diC7PC, ranged 
from 1.59 to 2.48 mM. If the CMC for pure diC7PC (1.5 mM) is subtracted from the 
bulk PC concentrations, and the resultant curves fit (except for I43A) with a 
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hyperbolic function (Figure 6B), we obtain apparent micelle Kd values that show a 
more striking change in micellar PC affinity (Table 3-2). Removal of the hydrophobic 
side chain of Ile43 or placing a Trp at this position and an Ala at 47 generates enzyme 
with weaker affinity for diC7PC micelles. The swap mutant (I43W/W47I), I43W, and 
K44A all bind slightly more tightly to PC micelles than native PI-PLC protein (Table 
3-2). Interestingly, K44A shows less than half the fluorescence change of native 
PI-PLC (Figure 3-6), indicting a difference in the environment of the fluorophore in 
this mutant. In a monomeric protein structure residue 44 is not close to Trp242. 
However, in the W47A/W242A dimer, the helix B residues are much closer to the 
Trp242 in the rim loop. 
E.  PI-PLC induced aggregation of diC7PC 
PI-PLC binding to diC7PC micelles can also be monitored by the increase in 
the 31P linewidth of diC7PC when the protein is present.1b The width at half height, 
∆υ1/2, for the phosphorus resonance is broad in the presence of PI-PLC protein as 
soon as the diC7PC concentration is greater than the CMC (Figure 3-7). The very 
large increase in 31P linewidth when protein binds to micellar diC7PC reflects a 
combination of aggregation of the protein/diC7PC system10 and slower exchange 
between monomer, micelle, and enzyme-bound diC7PC such that the exchange is 
intermediate on the NMR time-scale.4 At high concentrations of diC7PC (~15-20 mM), 
the limiting linewidth of the phosphorus in the presence of rPI-PLC is much larger 
than that for pure diC7PC micelles. At 20 mM diC7PC, if the diC7PC molecules were 
in fast exchange between monomer, micelles, and enzyme-sites, the weight-averaged 
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linewidth should approach the linewidth of pure diC7PC. That it does not for native 
PI-PLC is consistent with a PI-PLC/diC7PC complex that is considerably larger than 
pure diC7PC micelles.  
The same titration experiments carried out for I43W and I43W/W47I show 
much smaller increases in 31P linewidth right above the CMC and much smaller 
limiting linewidths (Figure 3-7). Both mutants exhibit K0.5 values for diC7PC similar 
to native PI-PLC as measured by intrinsic fluorescence changes. From the difference 
in diC7PC 31P linewidths in the absence and presence of protein at PC concentrations 
above the CMC, a ‘bound’ linewidth, ∆b, (extrapolated broadening of one diC7PC 
molecule caused by one PLC) can be estimated as well as an excess limiting particle 
linewidth, which must reflect increases in the average protein/lipid mixed micelle 
particle size. For native PI-PLC, that value, ∆b, is 373±41 Hz; this ‘bound’ linewidth 
is reduced to 36.1±5.7 Hz for I43W/W47I and 14.1±6.6 Hz for I43W. The limiting 
excess particle linewidth is 5.9±1.6 Hz for native PI-PLC, 3.2±0.2 Hz for the double 
mutant and essentially zero (0.30±0.27 Hz) for I43W. Since all three species are quite 
active, this suggests that the aggregate structure per se is not responsible for diC7PC 
activation of cIP hydrolysis. Rather the aggregation upon interaction with diC7PC 
micelles is likely to reflect placement of the hydrophobic Trp residues at the rim of 
the PI-PLC barrel and the size and orientation of the hydrophobic plug this produces. 
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Figure 3-7 (A) 31P linewidth (Hz) of the diC7PC phosphorus resonance in the 
presence of 3 mg/ml WT (), I43W (), or I43W/W47I. (■) PI-PLC. For 
comparison the linewidth for diC7PC as a function of concentration without 
enzyme is shown (bold line). (B) Difference in diC7PC line width (∆∆υ1/2) in the 
presence of PI-PLC for the three PIPLC enzymes 
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III. Discussion  
Previous studies of the crystal structure of the interfacially impaired B. 
thuringiensis PI-PLC W47A/W242A established that there is a major conformational 
change in two regions of the protein. Based on the structure of the monomeric B. 
cereus PI-PLC,2 the helix B region (Ile43 to Gly48) in wild-type PI-PLC, whose Trp 
residue has been proposed to partially insert into the membrane,3a,c orients the side 
chains of Ile43 and Trp47 (and possibly Val46 as well) so that they pack together and 
form a hydrophobic protrusion that extends outwards toward solvent. In the 
W47A/W242A mutant structure,5 the helical secondary structure of this segment has 
been disrupted to form an extended loop. The rim loop that would contain Trp242 has 
also been displaced. The removal of the two Trp residues thought to insert into 
membranes could explain the loss of PC binding and low phosphotransferase and 
cyclic phosphodiesterase activities. However, an unexpected and very interesting 
feature of this double mutant was that PI-PLC W47A/W242A exists as a homodimer. 
Residues in the helix B region, notably Pro42 and Gln45, play important roles in 
stabilizing this dimer. The key question is whether a dimer forms with native PI-PLC 
and, if so, how close the structure of W47A/W242A is to the ‘active’ dimer. 
Formation of a dimer at the membrane surface is appealing because it could provide 
the protein with an easier means of processive catalysis – release of water-soluble 
products by one subunit could occur with the other still tightly anchored to the 
membrane. Mutation of three or more of the tyrosine residues that form the 
hydrophobic core of the dimer interface in W47A/W242A dramatically reduce 
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PI-PLC phosphotransferase and phosphodiesterase activities.6 Those results could 
support a dimer as the membrane-bound form of this PI-PLC. However, whether or 
not helix B is intact in the membrane-bound form still needs to be addressed. 
The results in this study of mutating residues in the helix B region of PI-PLC 
are consistent with dimer formation, although they do not prove that dimers form. 
Q45A has reduced affinity for PC interfaces. Yet if helix B is intact, the residue at 
position 45 should not contribute to membrane binding (or dimer formation) since it is 
on the opposite face of helix B (Figure 3-2 D). With an intact helix B, both Ile43 and 
Trp47 should dominate binding of the helix to the membrane. The reduced PC 
activation of Q45A indicates that the membrane-active conformation of the enzyme is 
less favorable with this mutation, supporting the hypothesis that helix B is unlikely to 
remain intact at the membrane surface. In the W47A/W242A dimer, Gln45 forms a 
hydrogen bond with Gly239 of the other subunit (Figure 3-2E). If this contributes to 
dimer stabilization at the membrane, Gln45 removal would be expected to reduce PC 
affinity and reduce enzyme activities, and indeed both cIP and PI cleavage were 
reduced with the Q45A mutation. Pro42 is also involved in dimer stabilization in 
W47A/W242A. However, P42G could also alter helix B formation and orientation – 
the introduction of a very flexible residue allows the enzyme to have much greater 
variability in the helix B region. Interestingly, diC7PC activation of cIP hydrolysis is 
affected with only small affects on PI cleavage. This could suggest that the presence 
of acyl chains on the bound substrate also contribute to dimerization of PI-PLC.  
Leu39 provides an interesting wrinkle on membrane binding and dimer 
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formation of B. thuringiensis PI-PLC. Like W47A, L39A binds very poorly to PC 
vesicles. Furthermore, the magnitude of the drop in affinity is much greater than 
would be predicted if an alanine rather than a leucine side chain partitioned in the 
membrane. In the crystal structure of B. cereus PI-PLC2 as well as the W47A/W242A 
dimer,5 Leu39 is embedded inside the enzyme and should not have a significant effect 
on PC binding. The significantly weaker binding of L39A to POPC vesicles suggests 
a membrane-active dimer is not exactly the same as the W47A/W242A dimer and that 
there is a conformational change in this region of the barrel rim that either orients 
Leu39 outward so that it can partition directly into the PC surface or positions this 
residue to interact with the initial portions of the hydrophobic acyl chains of the 
substrate.  
A proposed model for activation of B. thuringiensis PI-PLC is shown in Figure 
3-8. PI-PLC in solution has an intact helix B (shown in green) that keeps the enzyme 
as a monomer and prevents premature dimerization (conformation A in Figure 3-8). 
Solution dimerization, were it to occur, might prevent tight binding of the protein to 
membranes since the resultant dimer (based on W47A/W242A) has a highly concave 
surface.34 An intact helix B also provides the hydrophobic surface for the initial 
binding of the protein to a PC membrane (or a PC-enriched region in mixed 
substrate/PC bilayers). Once contact occurs, Trp47 is inserted into the 
bilayer/interface. The insertion of Trp47 could trigger a rearrangement of helix B 
residues altering both the position and structure to an extended loop that could 
provide several points of contact, Ile43 and Val46 as well as Trp47, with the 
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membrane (conformation B in Figure 3-8). Membrane anchored protein monomers 
can now dimerize on the PC-containing membrane surface via Tyr246, Tyr247, 
Tyr248, and Tyr251 residues6 with both Pro42 and Gln45 part of the dimerization 
network. Enhanced PI cleavage to cIP would in part reflect the increased lifetime of 
the protein dimer on the membrane. However, other changes must occur for cIP 
hydrolysis to also be activated by PC interfaces. Work by us1,3,4,11 and others12,10 has 
suggested there is a conformational change in the Bacillus protein (as also suggested 
in a similar PI-PLC from Listeria monocytgenes13) when it binds to activating 
interfaces that increase kcat and decrease the apparent Kd for membranes. This is 
reflected in a tighter affinity for activating interfaces3a,c and an increased inhibition of 
cIP hydrolysis by substrate analogues such as PA or PMe.11 In a W47A/W242A-like 
dimer, the accessibility of active site residues is altered to present a more extended 
surface 34 that could alter how the activator and substrate molecules bind to PI-PLC.  
 
Figure 3-8.  Model for the role of helix B residues in PI-PLC activation by PC 
interfaces. 
 
 
There are also likely to be more subtle changes in the active sites of the dimer 
that modulate the catalytic step. The transformation of PI to cIP occurs by His32 
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acting as a general base to deprotonate the inositol C(2)-OH so it can attack the 
phosphate group. His82 then acts as the general acid to protonate the DAG leaving 
group. In the second step (cIP hydrolysis to I-1-P) water, deprotonated by His82 
acting as a general base, acts as a nucleophile to attack the phosphorus while 
protonated His32 contributes a proton to the inositol C2 oxygen. It has been suggested 
that the catalytic triad of His82-Asp33-Arg69 is not optimally arranged to catalyze the 
hydrolysis of cIP.14 Rather, hydrophobic interactions of the rim and perhaps the 
hydrocarbon chains of the PI substrate facilitate the changes necessary for optimal 
catalysis (hence PI cleavage will be much faster than cIP hydrolysis). For cIP in 
solution, both His32 and His82 would have the ‘wrong’ initial ionization states. 
Enhancing catalysis, particularly for the second step, would be provided by an 
allosteric pathway between helix B residues and catalytic residues that shifts local 
pKa values so that enhanced bond cleavage occurs. Binding to a PC interface provides 
this local change while not binding to the active site in place of cIP. Gly48, at the 
C-terminal end of helix B, would appear to be a key residue in this process. In 
structures of the B. cereus PI-PLC and W47A/W242A, Gly48 is close to His82 (< 4 Å 
separation). While the binding of G48A to PC is very similar to native PI-PLC, the 
activities for both PI cleavage and cIP hydrolysis are lower than WT. What’s more, 
the activation by PC for cIP hydrolysis is dramatically decreased for this mutant 
relative to native PI-PLC (3-fold versus 22-fold). Since binding to PC induces 
conformational changes of the enzyme, Gly48 might be a very important site for 
communicating with the active site His82 about the conformational change of the 
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helix B region. 
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Chapter 4 
Mutagenesis Studies of Rim Hydrophobic Residues of Bacillus 
thuringiensis PI-PLC 
I. Introduction 
In order to better understand the function and regulation of PI-PLCs, which are 
peripheral membrane proteins, it is very important to investigate the interaction 
between the enzyme and the lipid bilayer. The B. thuringiensis PI-PLC, as a model 
system of the catalytic domain of mammalian PLCs that play important roles in signal 
transduction, has been shown to interact with zwitterionic surfaces (e.g., 
phosphatidycholine (PC)) via two tryptophan residues (Trp47 in two-turn helix B and 
Trp242 in a disordered loop) at the rim of the barrel structure.1 The association of 
PI-PLC and the lipid bilayers may also cause conformational changes, but the result 
of this interaction is activation of the catalytic activity of the enzyme. A crystal 
structure of an interfacially impaired mutant W47A/W242A was solved,2 and this 
enzyme forms a dimer with significant conformational rearrangement of the loop and 
helix B residues. Whether the active form of btPI-PLC is a monomer or dimer is not 
known. 
Figure 4-1 shows a fragment of the surface of this bacterial PI-PLC. In addition 
to the Helix B region (highlighted in green) that has been shown to have a strong 
influence on the binding of the enzyme to the membrane, a string of residues forming 
the separate hydrophobic core of this interface (highlighted in blue) are also very 
close to the active site (highlighted in red), and therefore could have significant 
 effects on the interfacial binding o
positively charged in the region. Among the interesting residues in this region are
His81, Leu85, Tyr86, Tyr88, and Tyr
the active site and might be involved in direct 
is difficult to tell which ones contribute to the interaction 
membrane surface from the crystal structure 
interface, mutation studies of these residues individually as well as in combination 
were carried out and their effect on activity of the enzyme and PC binding will be the 
focus of this chapter. 
Figure 4-1. Surface representation of 
red, Helix B in green and rim residues in blue).
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II． Techniques to characterize protein/membrane interactions 
There are several techniques available to study the interaction of proteins with 
membranes including centrifugation, fluorescence and NMR. Here we used intrinsic 
fluorescence of the PI-PLC and high resolution field cycling 31P NMR (fc-P-NMR) to 
study the protein-lipid interaction.3 Intrinsic fluorescence is a method that senses the 
interactions based on the quenching of intrinsic fluorophores Trp, Tyr and Phe. 
Because most of the emissions are due to excitation of Trp residues based on the 
quantum yields and lifetimes, the fluorescence spectrum of a protein containing these 
residues usually resembles that of Trp. The intensity, quantum yield and wavelength 
of maximum fluorescence emission of Trp are highly solvent dependent with the 
intensity of the fluorescence increased when the polarity of the solvent surrounding 
the Trp residues decreases. Trp fluorescence can be quenched by a neighboring 
quencher such as a dibromo- or nitroxide group. One shortcoming of the method is 
that the intrinsic fluorescence only shows the overall protein-lipid binding but not the 
details.  
31P NMR is an alternative choice for studying the interaction because PI-PLC can 
recognize the head groups of substrate, analogue, and activator phospholipids and 
these have different 31P chemical shifts. A traditional method is to monitor the 
increase of the line width of the 31P resonance upon protein binding, but the limitation 
for this method is poor resolution and large line widths of resonances for 
phospholipids in vesicles at the high fields of modern instruments. An alternative 
method is the high resolution field cycling 31P NMR (fc-P-NMR) spin-lattice 
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relaxation technique, which resolves the dynamics of each phospholipid component in 
mixed phospholipid vesicles through monitoring relaxation rates over a wide range of 
magnetic fields. 4  Over most of the accessible high field range chemical shift 
anisotropy (CSA) has more contribution to 31P relaxation than the dipole-dipole 
interactions, even when small phosphorus-containing molecules are free in solution. If 
the small phosphorus-containing molecules are bound to a large complex such as an 
enzyme, their observed relaxation rate, R1, becomes much larger. The extent of the R1 
change is related to the binding affinity and size of the transient aggregate. If there is 
an excess of ligand molecules compared to the enzyme and bound and free ligand are 
in fast exchange on the NMR timescale, then the field-dependent R1 depends on the 
ratio of ligand/protein and the proximity of the 31P to the nearby proton dipoles that 
relax it. Adding an electron-spin label to the protein near a suspected phospholipid 
binding site can enhance the effect on the 31P. For this nucleus, the much larger 
magnetic dipole of the electron is much more effective than nearby protons, even with 
a high ligand/protein ratio. To vary the magnetic field, the sample is mechanically 
shuttled between the center high field region of the commercial NMR magnet's probe, 
and a substantially lower magnetic field located above the probe before, and after, the 
delay times normally used in spin-lattice relaxation rates. This allows us to obtain 
relaxation rates over a wide field range (0.002 to 11.7 T). The shape of the R1 versus 
field curve provides several correlation times (τ) for each phospholipid molecule on 
timescales ranging from ps to µs. This method can provide information on the 
location of any discrete phospholipid sites on the protein. 
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The binding energy of B. thuringiensis PI-PLC to a phospholipid interface is a 
sum of different energies, most of which are from van der Waals contacts and 
electrostatic interactions. Dr. Nathalie Reuter at the Department of Molecular Biology 
in the University of Bergen, Norway, carried out explicit molecular dynamics 
simulations adding this PI-PLC into to a pre-equilibrated dimyristoyl-PC (DMPC) 
bilayer with solvent present. A protein was added to each side of the bilayer. In these 
simulations (20 ns in total), four distinct interactions of a PC with the protein 
molecule were observed with two PC molecules binding to each monomer (Figure 
4-2). Interestingly, the interactions on each side were not the same – different regions 
of the protein formed what appeared to be discrete complexes with a PC headgroup. 
The choline headgroup can be involved in π-cation interactions with aromatic 
residues, and B. thuringiensis PI-PLC has many tyrosines located in regions that are 
likely to be in the proximity of the membrane surface. The simulation suggested that 
Tyr86, Tyr 88, Tyr204, Tyr246, and Tyr251 along with Trp242 could participate in 
formation of these transient complexes,  
Of the many Tyr residues in the rim region above the active site of the protein, 
replacement with alanine at several sites (close to helix B as well as the active site) 
was carried out to investigate the interactions between enzyme and membrane. A loss 
in PC vesicle binding affinity suggests that the interaction seen in the simulations may 
indeed contribute to transient anchoring of the protein to the surface.  
 Figure 4-2. Snapshots of
trajectory of BtPI-PLC binding a DMPC bilayer. This explicit membrane 
molecular dynamics simulation was carried out by Nathalie Reuter, University of 
Bergen, Norway. (a) Positions of the ar
interactions with the choline group. (b) Pocket formed by Tyr204 and Tyr251, 
and double partner of Tyr251. (b) Pocket formed by Tyr246 and Trp242. (d) 
π-cation interaction of Trp47. (e) Interaction of Tyr86 and Tyr88.
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Also generated were mutations where His81 and Leu85 were changed to alanine 
since these residues are also in the region around the top of the active site and might 
contribute to electrostatic binding to phospholipid surfaces – the lysine supplies a 
cation to interact with any negatively charged phospholipids, while the histidine may 
be partially cationic. We would expect these two mutant proteins to have only 
moderately changed affinities for PC but a possible reduction in binding to vesicles of 
an anionic phospholipid that mimics the substrate (e.g. phosphatidylglycerol, PG, or 
phosphatidylmethanol, PMe). 
III. Results 
A. Secondary structure and thermal stability of mutated PI-PLCs 
 Mutations of His81, Le85, Tyr86, Tyr88 or Tyr118 to alanine were prepared, 
together with double and triple mutants of these positions. CD spectra of WT and 
mutant PI-PLCs were used to check for the overall conservation of the secondary 
structure of the enzymes. The thermostability of the enzymes was measured by 
monitoring the loss of secondary structure at 222 nM with temperature. The proteins 
denature irreversibly so this is not an equilibrium experiment. However, it allows us 
to see if there are any many changes in protein structure.  
 Table 4-1 summarizes the estimates of native PI-PLC and mutant secondary 
structure calculated from the CD wavelength spectra by CDNN. While L85A, Y86A, 
and Y118A had the same secondary structure as native protein, H81A, Y88A, double 
mutant Y86A/Y88A and triple mutant Y86A/Y88A/Y118A exhibited reduced α-helix 
content and increases in β-sheet and random coil structure. All mutants had similar Tm 
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values to that for WT protein – values were 54-57oC compared to the 57oC for the 
native (WT) protein.  
Table 4-1. Secondary structure and Tm of mutated PI-PLC enzymes. 
enzyme 
Secondary Structure (%) Tm 
oC α-Helix β-Sheet β-Turn Random Coil 
WT 26.3 20.6 17.6 35.4 57 
H81A 21.1 23.4 17.9 37.7 55 
L85A 26.0 20.7 17.7 35.5 55 
Y86A 28.5 19.4 17.5 34.6 56 
Y88A 20.3 23.8 17.8 38.1 56 
Y118A 28.7 19.4 17.5 34.5 54 
Y86A/Y88A 23.3 22.0 17.6 37.0 56 
Y86A/Y88A/Y118A 20.5 23.5 17.8 38.1 54 
  
B. Phosphotransferase and cyclic phosphodiesterase activity 
 The enzymatic activities of these enzymes bearing surface mutations were 
measured using a detergent (diC7PC) mixed micelle system to monitor PI cleavage 
(the phosphotransferase step) and cIP hydrolysis in the absence and presence of 
diC7PC to monitor the phosphodiesterase activity and ability of a PC interface to 
activate the enzyme (Table 4.2).  
 Two of the altered enzymes exhibited a reduced phosphotransferase activity  
compared with native PI-PLC. H81A and L85A had PI cleavage rates of 40% and 51% 
of what WT enzyme showed. Y86A and the double and triple mutants were 
comparable to WT. Interestingly, Y88A and Y118A were significantly more active 
than WT. 
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Table 4-2. Specific activities of the mutated PI-PLC enzymes. 
Enzyme PI (8 mM) 
a 
µmol min-1 mg-1 
cIP (20 mM) 
µmol min-1 mg-1 
cIP/diC7PC b 
µmol min-1 mg-1 
Ratio of cIP 
activity     
± diC7PC 
WT
 
955 
 
2.80 
 
62.5 
 
22.3 
 
H81A
 
386
 
0.1 
 
4.56 
 
44.1 
 
L85A
 
484
 
1.14 
 
7.41
 
6.5 
 
Y86A
 
1022
 
1.01 
 
29.9 
 
29.7 
 
Y88A
 
2790
 
1.50 
 
41.6 
 
27.8 
 
Y118A
 
1961
 
2.32 
 
43.9 
 
18.9 
 
Y86A/Y88A
 
1253
 
0.9 
 
14.9 
 
15.8 
 
Y86A/Y88A/Y118A
 
1033
 
0.5
 
5.1 
 
10.0 
 
a
 The PI is solubilized in 32 mM diC7PC. Specific activity values are ± 20% 
b
 5 mM diC7PC was added to the 20 mM cIP sample to test PC 
activation. .Specific activities are <20% of the value tabulated. 
   
A comparison of the cIP hydrolysis rates in the absence and presence of diC7PC 
is shown in Table 4-2 for these rim hydrophobic residue mutants. In the absence of 
any interfaces, all the mutants had cIP cleavage rates of 32 to 83% of WT enzyme 
activity except for H81A, and Y86A/Y88A/Y118A, which exhibited 4% and 18% of 
the rate of WT. Addition of diC7PC micelles increased all the activities with the 
activation-fold (ratio of the activity in the presence of PC compared to that in its 
absence) comparable to WT for Y86A, Y88A, and Y118A. L85A had the least 
activation by diC7PC (an increase of only 6.5-fold). H81A was significantly activated, 
although the final specific activity was still much less than WT (Table 4-2). 
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Y86A/Y88A and Y86A/Y88A/Y118A were both much less sensitive to kinetic 
activation by this non-substrate phospholipid suggesting either a reduction in diC7PC 
affinity or an altered binding of the protein to these micelles.  
C. Binding of PI-PLC enzymes to PC vesicles 
Previous studies have shown that the intrinsic fluorescence intensity of B. 
thuringiensis PI-PLC increases with binding of the protein to PC activator micelles or 
vesicles, while fluorescence intensity decreases with ligands such as PA (phosphatidic 
acid) or PG (phosphatidylglycerol) binding to the active site.5 Out of the seven 
tryptophans that all contribute to the intrinsic fluorescence emission, two of them 
(Trp47 and Trp242) located at the binding surface, in particular, were responsible for 
most of the spectral change upon interfacial binding. The rim hydrophobic residues I 
mutated are spatially close to these two tryptophans according to the B. cereus 
PI-PLC crystal structure. The structural or conformational changes caused by 
mutations of these residues, therefore, may affect the fluorescence intensity. To assess 
this, the fluorescence intensities of H81A, L85A, Y86A, Y88A, Y118A, Y86A/Y88A 
and Y86A/Y88A/Y118A were examined at 337 nm, the maximum emission 
wavelength, as POPC SUVs were added. Fitting the increase in fluorescence as a 
function of PC concentration provides a measure of the binding affinity of the enzyme 
for the vesicles. Figure 4-3 shows a typical binding profile for Y88A binding to PC 
SUVs. The apparent Kd value is the bulk PC concentration for half the maximum 
fluorescence change. 
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Figure 4-3. (A) Change in intrinsic fluorescence for Y88A (0.02 µM) as a function 
of added POPC SUVs. (B) Titration curves for Y88A binding to POPC SUVs. 
The lines through the data represent the best fit. 
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The apparent Kd values for the different proteins are summarized in Table 4-3. B. 
thuringiensis PI-PLC binds tightly to POPC SUVs with an apparent Kd = 0.078±0.009 
mM. Of these rim hydrophobic residue mutations, only Y118A was close to WT 
(2-fold weaker). H81A, L85A, and Y86A were 5-6-fold weaker. For the leucine and 
tyrosine substitutions this loss of binding affinity is about what one would predict 
based on free energies of transfer of leucine and tyrosine side chains versus alanine.6. 
Y88A had a larger change for the PC Kd than expected based on membrane insertion. 
The double and triple ,mutant proteins showed weaker binding to PC, but not quite as 
large a chain if these side chains partitioned into the bilayer. However, partial 
insertion, as might occur for π-cation interactions with the choline group, could easily 
account for the successive increases in Kd.  
Table 4-3. Apparent dissociation constants for mutated PI-PLC enzymes to PC 
vesicles. 
Enzyme Apparent Kd  (mM) Kd mutant/ Kd WT 
WT 0.078±0.009 1 
H81A 0.50±0.13 6 
L85A 0.46±0.13 6 
Y86A 0.37±0.11 5 
Y88A 0.94±0.07 12 
Y118A 0.15±0.03 2 
Y86A/Y88A 0.68±0.25 9 
Y86A/Y88A/Y118A 1.77±0.33 23 
 
 What is striking about the vesicle binding data is that tight binding and high 
specific activities are not necessarily correlated. Y118A has about twice the specific 
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activity of WT for PI cleavage and within a factor of two for the PC Kd. However, 
Y88A has the highest PI cleavage rate but the weakest binding to PC SUVs. The other 
notable observation is that removing Tyr86 and then looking at the double and triple 
Tyr mutant proteins, one sees that PI cleavage is only moderately affected while there 
is a much more pronounced loss of cIP hydrolytic activity, particularly in the presence 
of diC7PC. For the triple mutant, the lack of a large PC activation is not caused by 
poor PC binding, because in the assay the diC7PC concentration is 8 mM, 
significantly above the 1.77 mM Kd. There must be some changes affecting 
productive binding of substrate in the active site that are not important if the substrate 
has acyl chains but are critical for cIP hydrolysis. It is as if the PC acyl chains cannot 
bind in a specific manner that usually enhances cIP hydrolysis. 
D. Searching for specific phospholipid binding sites on PI-PLC by field cycling 31P 
NMR  
Spin-lattice relaxation fc-P-NMR can provide more details about the location of 
spin labels relative to vesicle components. When the spin-label is close to the 
phospholipid and a complex with a lifetime of at least a microsecond is formed, the 
major contributor to 31P dipolar relaxation is the 31P electron interaction. Thus, these 
types of experiments provide two types of information: (i) if a transient 
phospholipid/protein complex does indeed form, and (ii) what the averaged nitroxide 
to 31P distance is for that complex. Since multiple PC molecules might bind to the 
protein, effects may be averaged. However, previous work with the B. thuringiensis 
PI-PLC showed that for PMe/PC (1:1) vesicles, a spin label on D205S was close to a 
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PC molecule, while the label on W47C or H82C was closer to PMe, which binds at 
the active site.4 
These experiments used 0.5 mg/ml (0.014 µM) protein bound to total 10 mM 1:1 
PC/PMe mixture SUVs, so the mole ratio of protein/phospholipid molecules is ~1/700. 
At high field, most of the 31P relaxation is not dipolar, which makes it impossible to 
see effects of the spin-labeled protein unless the protein concentration is very high. At 
that point the SUV surface is covered with spin-labeled protein and electron spin-spin 
interactions can occur that complicate interpretation of any observed effects. At low 
fields (<0.02 T), the 31P relaxation, in the absence of spin-labels, is affected by a few 
nearby protons that results in a clear and easy-to-see dispersion. In this region a 
nearby electron spin-label has a very large and easily detected effect on the nuclear 
spin. What is important is that the effect of each phospholipid varies and therefore the 
patterns for PC and PMe are different, indicating they have distinct apatial locations 
when bound to the protein. Spin-lattice relaxation rates (R1 = 1/T1) can be obtained 
over a wide range of magnetic field strengths. The field dependent of R1 can then be 
analyzed to obtain correlation times for the electron-31P interaction and the magnitude 
of the relaxation enhancement.  
To explore the binding of rim hydrophobic residue mutants to SUVs, we used 
mutant proteins where Leu85 or Tyr88 was altered to cysteine. They were chosen 
based on their activity and fluorescence results. L85A has reduced activity while 
Y88A has much higher activity than native PI-PLC (Table 4-2), and they both have 
lower PC SUV binding affinity compared with WT (Table 4-3). The Kd for L85A for 
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pure SUVs is higher than WT, but there is no information available for PMe binding, 
which prompted us to carry out the measurements with fc-P-NMR. In order to 
introduce a much larger dipole in the place where the phospholipids may bind, a 
nitroxide spin-label, MTSL, was covalently linked to the cysteine. 
The phosphotransferase activities of L85C and Y88C were checked before the 
fc-P-NMR measurements. Table 4-4 lists the results for the dimeric (disulfide-linked), 
monomeric (with excess reducing agent) as well as the spin-labeled enzymes. A 
PI/diC7PC assay system was chosen so that only active site binding might be reflected. 
It is interesting to note that the change in activity is more dramatic for L85C than 
Y88C. The activity of the L85C monomer is close to that of L85A, already a poorer 
enzyme than WT. A dimer formed at this position really reduces activity – possibly by 
reducing substrate accessibility to the active site. The activity of L85C with spin-label 
attached is about a factor of two lower than that of unlabeled enzyme, again probably 
because the steric size of the attached label makes it more difficult for the substrate to 
enter the active site. In contrast, the spin label on Y88C has little effect on 
phosphotransferase activity. 
Table 4-4 Phosphotransferase activities (PI(8 mM)/diC7PC(32 mM)) of PI-PLC 
enzymes with a cysteine substitution in the proposed membrane binding region.a
  
Enzyme Dimer Monomer Spin-labeled 
N168C 1500 1630 – b 
L85C 85 532 279 
Y88C 641 979 812 
a
 Errors in specific activities were typically <15% of the tabulated value. 
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b Previous assay of the modified protein by M. Pu indicated there was no significant 
change in the activity of the modified protein.  
The field dependence profiles for spin-labeled PI-PLC (0.5 mg/ml, 14.4 µM) in 
the 10 mM PC/PMe (1:1) SUVs are summarized in Figure 4-4. The fit in the mid to 
high field region provides information on protein binding and general membrane 
proximity and not a specific phospholipid/protein complex since the correlation time 
characterizing this region is ~5 ns in the absence of of protein7  and 10-15 ns if 
unlabeled protein is present.8 
As shown in Figure 4-4A, τc for PMe, 3.9±0.9 ns, is similar to the values for the 
same vesicles without protein, 5.0±1.1 ns, so it is unlikely that PMe is binding well. In 
contrast, there is a pronounced relaxation effect of the spin-label on PC in the same 
SUVs. The curve is shifted to the left indicating a longer correlation time consistent 
with protein restricting motion of the PC. The τc extracted for PC, 13.2±3.6 ns, is 
noticeably greater than for SUVs without protein (5.5±0.9 ns). Effects of the 
spin-labeled protein on the magnitude of the relaxation rate are small in this region. 
The low field region is a better indicator of phospholipid/spin-labeled protein 
proximity. As shown in Figure 4-4B, both relaxation rates increase at lower field. To 
assess how much of this behavior is caused by proximity to the spin-label on the 
protein, we subtract the control for unlabeled protein at this concentration binding to 
the vesicles (Figure 4-4C). The residual or excess relaxation rate, ∆R1, due to the 
spin-labeled protein varies with magnetic field and is related to on average how close 
the spin-label site is to a particular phospholipid when it is bound to the protein. 
 
104 
 
Figure 4-4. Field dependence of 5 mM each PMe (4) and PC (3)31P relaxation 
rates in the presence of spin-labeled L85C (14 µM): (A) mid-to-high field data; 
(B) low field data; (C) R1 due to spin-label(control R1 with unlabeled protein 
subtracted). 
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by the electron: 
     ∆R1 = ∆RP-e(0)/(1 + ωP2 τP-e2) 
where ∆RP-e(0) is the limiting relaxation at zero field, and τP-e is the correlation time 
for this interaction. The parameter ωP is the magnetic field strength H (in Tesla) times 
the magnetogyric ratio for 31P: ωP = γP H. The distance of the 31P to the spin-label, rP-e, 
is derived from the following: 
rP-e
6
 = ([PI-PLC]o/{(2/3)[lipid]o) x ( S2 τP-e /∆RP-e(0)) (0.3 µ2(h/2π)2 γP2 γe2) 
This assumes in these SUVs that 2/3 of the total phospholipid is in the outer leaflet. 
The effect measured depends on fast exchange between phospholipid bound to the 
protein at a discrete site and the bulk pool of phospholipids in the vesicles.  
 For the analysis, τP-e was assumed to be 1 µs (based on extracting this parameter 
for spin-labeled PI-PLC variants that were closer to the phospholipid binding sites4). 
While it was expected that PMe in the active site should be relaxed by this label, little 
effect was observed, implying that the binding of PMe to the site is much weaker than 
assumed. No significant PMe complex exists with a lifetime ~ 1 µs. This is consistent 
with the low phosphotransferase specific activity of spin-labeled L85C. The excess 
PC R1 in the low field region that is due to the spin-labeled protein allows us to 
extrapolate ∆RP-e from Figure 4-4C and estimate the distance of the tight PC site to 
the spin-label at L85C as 16.5Å. 
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Figure 4-5. Comparison of R1 as a function of field for (A) 5 mM PMe and (B) 5 
mM PC in 1:1 SUVs with 14 µM spin-labeled L85C. The dotted lines show 
profiles for the controls (individual control R1 shown as +). The solid line for PC 
represents the fit to the points shown. 
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onto the SUVs. 
There appears to be a small rise above the control at 0.01T but the values are very 
close to the control. From the crystal structure one would have expected much higher 
R1 values for PMe – to values greater than 10 s-1 at 0.06 T. Since there is little effect 
of this spin-label on PMe, this again emphasizes that the PMe-protein complex must 
have a very short lifetime and/or a very high two-dimensional Kd. The R1 values for 
PC are also fairly close to the control, although the change is a little larger. The PC 
site is thought to be ~15 Å from the active site, so this is about the amount of 
relaxation one might expect with this ratio of labeled L85C to phospholipid.  
 All of these results point to the fact that L85A mutant protein might be an 
example of poor substrate binding but moderately reasonable PC binding. 
For spin-labeled Y88C PI-PLC, the relaxation profile was also interesting. This is 
a position where the tyrosine interacts with a phosphocholine headgroup in the MD 
simulation. However, in this mutant protein we have replaced the aromatic group with 
a cysteine and added a spin-label to it. Nonetheless it is still in the region around the 
active site, so we expected some effect of the spin-label at this position on the PMe 
31P relaxation rate at low field. Figure 4-6 shows the field dependence of R1 for PC 
and PMe in the presence of the spin-labeled Y88C. What is striking is that in the 
mid-field region (Figure 4-6A), the profile for both PMe and PC have significantly 
increased Rc(0) values – this value is typically ~ 1 s-1 for pure PMe/PC vesicles and 
increases a small amount with unlabeled protein (at 1 mg/ml) added. Here the value 
for the limiting R(0) for this dispersion is 1.7-1.8 s-1. This indicates the position of the 
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spin-label is certainly in the vicinity of the membrane.  
Figure 4-6. (A) Mid to high field region and (B) low field region showing the 
variation of 31P R1 with magnetic field dependence for PMe (5 mM)/PC (5 mM) 
SUVs with 14 µM Y88C PI-PLC: (3) PMe; (4) PC.  
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The low field region, which reports on the phospholipids binding to a specific site, 
does not show a large effect for either phospholipid (Figure 4-6B). There are small 
effects on each, but nothing suggests a long-lived complex of the protein with PMe or 
close proximity of the spin-label to a PC site (although there is a small effect of the 
spin-label on PC relaxation). This is better illustrated in Figure 4-7 where the profile 
for each phospholipid is compared to the control (a comparable concentration of 
non-spin labeled protein). The ∆R1 due to the spin-label is shown as a function of 
field in Figure 4-7C. Clearly there is no discernible effect of PMe but there is a small 
effect on the PC. Fitting the excess relaxation data for PC shown in (C) provides an 
estimate of rP-e as 17.5 Å. This would indicate there is still a tight PC site, but off on 
the periphery of the protein, not near the active site in this protein. 
 Y88C is a reasonable enzyme, perhaps half as active as the cysteine control (and 
not quite as active as Y88A), but PMe does not stick long in the active site. We know 
both PMe and PC in the bilayer are close to the spin-label site from the excess 
relaxation in the 0.1 T dispersion. However, in the low field region there is no 
significant effect on PMe so when it binds to the active site it is there only for a brief 
period of time. Previous FCS studies of Y88A3 showed a Kd of 0.3 mM for Y88A 
compared to 0.01 mM for the native PI-PLC control binding to 1:1 PG/PC bilayers. In 
light of the fc-P-NMR results we would interpret this weaker binding as being 
primarily due to a shorter koff of PMe in the active site.  
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symbol indicates the behavior of the 
the spin-label for PMe (5
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IV. Summary 
The rim hydrophobic residues have very special interfacial locations that are 
close to both the active site and the membrane binding region, helix B, so we 
expected these residues would play a role in enzyme interfacial activation. A series of 
mutants of these residues (H81A, L85A, Y86A, Y88A, Y118A, Y86A/Y88A, 
Y86A/Y88A/Y118A) were constructed and characterized. All of the mutants had 
altered behavior compared with the wild type PI-PLC, especially L85A and Y88A.  
L85A had lower activity and more importantly this mutant exhibited only small 
activation by PC. PC activation is thought to involve some conformational change of 
the protein around the active site when PC binds and anchors the protein at a site 
distant from this region.9PC binding is weakened in L85C, but at the concentrations 
used in assays, the PC interactions should be saturated. Clearly, removal of the leucine 
at this position disrupts the ability of PC to enhance activity, even though the protein 
can still bind to PC vesicles. Field cycling experiments by Pu et al.4, suggested a 
discrete PC site existed on the periphery of the protein in the vicinity of Tyr204, 
Tyr246 and the other tyrosine residues in that region. That site may still be intact, 
since the field cycling does show a long-lived PC effect ~15-16 Å from the label on 
L85C. MD simulations suggest other π-cation interactions between the protein 
aromatic residues in PI-PLC and the PC headgroup, and it is possible that one of these 
is disrupted in L85C. However, the fc-P-NMR also shows that PMe does not bind 
well to spin-labeled L85C. The lower PI cleavage activity could result from 
misaligned substrate in a conformation where the allosteric effects of PC in enhancing 
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activity are less reduced. 
Y88A had really high phosphotransferase activity (3 fold higher than wild type in 
a PI/diC7PC mixed micelle assay) and lower interfacial binding affinity based on the 
results of intrinsic fluorescence and FCS.10 This tyrosine was observed to form a PC 
complex with Tyr86 in the MD simulations. Its removal does indeed weaken PC 
binding but the intriguing result is that activity is higher. If this π-cation interaction 
were absolutely critical to membrane binding, one would have expected a large 
decrease in activity. The high activity of mutant, spin-labeled or not, suggests such an 
interaction of Tyr88 with PC is transient at best and not really critical to activity under 
normal conditions. It may be that this interaction is what leads to surface dilution 
inhibition by PC of PI cleavage in vesicle systems.8Previous NMR and FCS results 
with native PI-PLC indicated that at high mole fraction of PC, the protein was 
sequestered in a PC-rich region and exchange of substrate and product into and out of 
the active site was reduced and that this was likely the cause of the observed surface 
dilution inhibition (loss of activity at fixed substrate concentration with increasing 
non-substrate – in this case PC). The observation that Y88A had weaker binding to PC 
and reduced surface dilution inhibition6 may, in fact, indicate that it is Tyr88 that is a 
major contributor to protein sequestration on a PC-rich vesicle.  
In summary, these initial studies suggest that with the more sensitive NMR 
technology we can explore the function of specific rim hydrophobic residues with 
respect to changes in substrate analog or activator PC binding.  
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Chapter 5 
Role of X/Y Linker in Interfacial Activation of a 
Mammalian PI-PLC 
I.  Introduction 
Mammalian PI-PLC isozymes play an important role in signal transduction 
pathway by catalyzing the hydrolysis of phosphatidylinositol 4,5-biphosphate 
(PI(4,5)P2) into the two secondary messengers of diacylglycerol (DAG) and inositol 
1,4,5-trisphosphate (IP3)1 (Figure 5-1). The level of the substrate, PI(4,5)P2 can 
directly regulate important biological processes, for example modulating activities of 
many ion channels.2 For the two products, DAG is an activator of protein kinase C 
(PKC) and IP3 functions as a universal calcium (Ca2+) mobilizing messenger. These 
processes are essential for various cellular processes including fertilization, division, 
differentiation, platelet shape change, aggregation, muscle contraction and hormone 
secretion. PI-PLCs can be activated by numerous hormones, growth factors, 
neurotransmitters, antigens, and other external stimuli.3 
Figure 5-1. PI-PLC catalyzed hydrolysis of PI(4,5)P2 generates DAG and IP3. 
 
 
115 
 
At least thirteen PI-PLC isozymes are expressed in humans: PLC-β1 to β4, 
PLC-γ1 and γ2, PLC-δ1, δ3 and δ4, PLC-ε, PLC-ζ, and PLC-η1 and η2.4 All of the 
PI-PLC isozymes are multi-domain proteins and share the same backbone that 
includes, from N-terminus to C-terminus, the PH domain, EF hand domain, X-Y 
catalytic domain and C2 domain (with the exception of PLC-ζ that lacks the PH 
domain). The N-terminal PH domain possesses a high affinity for PIP2.5 The EF hand 
domain is critical for catalytic activity6, although its function is unclear. Unlike most 
other EF hands, those in PLC do not bind Ca2+ tightly as deduced from the crystal 
structure7 where no Ca2+ ions were detected in this domain. The catalytic domain is 
composed of the X and Y domains separated by a linker region. 
The difference in the regulation of PLC-β, -γ, -ε isoforms can be partly explained 
by the specific regions beyond the common backbone (Figure 5-2). PLC-β isoforms 
contain a long C-terminal extension and can be activated by a wide range of stimuli 
from tiny odorant molecules to full-sized proteins.8 Activation by the latter requires 
specific combinations of Gα and Gβγ subunits to couple their effectors. Different 
regions of PLC-β interact with Gα subunit and Gβγ subunits which are released from 
heterotrimeric G proteins by activation of G protein-coupled receptors. The α subunit 
has high affinity for the extensive C-terminal tail of PLC-β isoforms, while the Gβγ 
subunit binds to the N-terminal PH domain.8 Different PLC-β isoforms have different 
affinity for the G protein subunits: PLC-β1 and PLC-β3 exhibit high affinity for the 
Gα subunit, while PLC-β2 and PLC-β3 are sensitive to the Gβγ subunit.9 Recently, 
Hicks et al. reported that a loop (X-Y linker) separating the two halves of the catalytic 
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TIM barrel occludes the active site of PLC-β2. Removal of X-Y linker constitutively 
activates PLC-β2 without ablating its capacity to be further stimulated by classical G 
protein modulators, indicating that PLC-β2 may have an autoinhibitory regulation 
mechanism.10 
PLC-γ isozymes (PLC-γ1, PLC-γ2) have an insertion, which is a split PH domain 
containing two Src homology (SH2) domains and an SH3 domain, between the two 
halves of the TIM-barrel catalytic domain. The PLC-γ isozymes are primarily 
regulated by various receptor tyrosine kinases.11 After growth factor binds to the 
receptor tyrosine kinases, the SH2 domains of PLC-γ1 mediate binding to 
auto-phosphorylated tyrosine residues and the Tyr783 of the PLC-γ1 is 
phosphorylated.12 PLC-γ isoforms can also be activated by a variety of receptors that 
lack intrinsic tyrosine kinase activity and by various non-receptor tyrosine kinases.ref 
As the largest PLC isoform, PLC-ε has two special domains: (1) an RA domain 
located at the C-terminus of PLC-ε mediates the interaction with Ras family small 
G-proteins; (2) a CDC25 homology domain, located at the N-terminus of PLC-ε, also 
mediates the interaction with Ras family small G-proteins.13 PLC-ε can also be 
stimulated by Rho family small G-proteins; this PLC plays an important role in cell 
proliferation.14 
Recently, two isoforms of PLC-η were independently identified: PLC-η1 and 
PLC-η2.15 PLC-η contains a long extended region at its C-terminus that shows no 
homology with any other protein. Both PLC-η1 and PLC-η2 isoforms exhibit 
Ca2+-dependent PI(4.5)P2 hydrolysis, while PLC-η2 can be activated by the Gβγ 
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subunit.16 There are no well-established protein activators for sperm-specific PLC-ζ 
which is uniquely sensitive to the concentrations of calcium. 
Figure 5-2. Domain organization of mammalian PLC isoforms (adapted from 
Katan, 2005). 
 
 
The regulation mechanism of PLCδ is not very clear. Previous work showed that 
PLCδ is uniquely sensitive to physiologically relevant concentrations of calcium, but 
there are other possible regulation mechanisms. Feng et al. reported that the 
high-molecular-weight GTP-binding protein Gh can stimulate PLCδ activity. 17 
Homma et al. reported that a protein similar to Rho-GAP can stimulate PLCδ 
activity.18 More recently, Ranjinder et al. reported PLCδ was inhibited after binding 
to the calcium-signaling molecule calmodulin (CaM), while addition of Ral reversed 
this inhibition.19 
The PH domain and C2 domains of PLC play roles in protein / membrane 
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interactions. Several PLC PH domains bind phosphoinositides tightly, and this aids in 
anchoring the enzyme to target membranes. The C2 domain binds Ca2+ and it is 
thought that this domain also contributes to membrane binding via forming a Ca2+ 
complex with anionic phospholipids.  
There is no direct report of interfacial activation of the catalytic domain of 
mammalian PI-PLC. In contrast, the Bacillus thuringiensis PI-PLC was shown to 
exhibit very specific activation upon binding to phosphatidylcholine-containing 
interfaces.20 Bacterial PI-PLC and the catalytic domain of the mammalian PI-PLC 
enzymes share very similar structures. 21  Studies also show that their catalytic 
mechanisms are also very similar. Therefore, bacterial PI-PLC is largely used as a 
model for mammalian PI-PLCs. In addition, Hicks et al. reported that the X-Y linker 
in the PLC-δ1 catalytic domain might also play an auto-inhibitory role.10 The X/Y 
linker is located on the protein surface above the active site. However, the X/Y linker 
region is very flexible and not observed (except for a few residues) in the PLCδ1 
crystal structure (Figure 5-3).22 The details of how the X/Y linker region regulates 
interfacial binding and catalytic activity have not been investigated. The basic 
structure of PLCδ1, which is one of the simplest mammalian PLC isoforms, makes it 
a good system for exploring this effect.  
In order to investigate the role of the X/Y linker region in interfacial binding and 
activation, a mutated enzyme with the deletion of residues 461-471 (∆11) that are 
located at the center of the X/Y linker region and full of negatively charged residues 
was constructed and characterized for kinetic activation. Micelles and large 
119 
 
unilamellar vesicles (LUVs) were used to measure interfacial binding and the 
corresponding enzyme activity. In order to study the different effects of substrate and 
nonsubstrate lipids, we monitored the binding in multi-component LUVs using 
fluorescence resonance energy transfer (FRET) at higher protein concentration and 
fluorescence correlation spectroscopy (FCS) at much lower protein concentration. The 
PI-PLC activity in micelles and LUVs was monitored using 31P NMR. The results 
indicate that the 11 residues in X/Y linker region play auto-inhibitory role in 
membrane binding and have an effect on protein activity.  
Figure 5-3. Crystal structure of mammalian PLCδ1 (X/Y linker shown in blue 
and active site shown in red).  
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II. Results 
A. Rat PLCδ1 activity towards PI in micelles 
The mammalian PLCs have similar catalytic residues, to the bacterial PLCs and 
catalyze the cleavage of substrates via a two-step mechanism. Ca2+, a cofactor in the 
mammalian enzyme, binds at the active site, and lowers the pKa of the inositol 2-OH. 
It is proposed to make direct contact with the transition state and the intermediate of 
the reaction, cIP. The interaction with cIP keeps this initial product bound in the 
active site and explains why the mammalian enzymes generate two water-soluble 
products at the same time (cIP and I-1-P in Figure 5-4 or their phosphorylated 
analogs).  
Figure 5-4 31P spectrum of a reaction mixture of PI(8 mM)/Triton X-100(16 mM) 
incubated with PLCδ1.  
 
 
 
 
 
In our kinetic assays, PI was chosen as the substrate (even though it is a poorer 
substrate than PI(4,5)P2, because it is considerably cheaper and more available than 
phosphorylated PI species. PI can be presented to PI-PLC in a range of different 
PI 
cIP 
I-1-P 
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matrices: micelles, small unilamellar vesicles, large unilamellar vesicles or 
water/organic solvent co-mixtures.23 Differences in PLC activity towards substrate in 
different types of interfaces can often provide insights into what factors control the 
activity of this enzyme. We monitored enzyme activity (µmol min-1mg-1) towards 
PI/TX-100 mixed micelles. PI hydrolysis was kept between 8-25% in order to obtain 
specific activities with errors < 20%. TX-100 is a nonionic detergent that solubilizes 
PI bilayers at TX-100/PI >2.23 c  
As shown in Table 5-1, the phosphotransferase activity of the deletion mutant 
PLC-δ1 ∆11 towards PI (8 mM) in TX-100 (16 mM) mixed micelles was increased 
significantly (4-fold) compared with the wild type (WT) enzyme. Increasing TX-100 
at fixed PI concentration (8 mM) will eventually “inhibit” the enzyme if the surface 
concentration of PI is important for rat PLCδ1 activity. This phenomenon, termed 
‘surface dilution inhibition,’ has been documented for the B. thuringiensis PI-PLC.26 
Increasing TX-100 concentration to 32 mM led to a drop in the PLC specific activity 
for both ∆11 and WT. However, the relative specific activity of ∆11 compared to WT 
was essentially the same. Keeping the ratio of PI/TX-100 fixed but decreasing the 
total concentration of PI (4 mM) in TX-100 (8 mM) again led to a drop in the specific 
activity with the decrease in activity larger for WT than for ∆11 - a result that might 
suggest better substrate binding characteristics for the deletion mutant. The consistent 
increase in activity with the removal of the linker region rich in acidic residues is in 
keeping with this section of the protein acting as an autoinhibitor. 
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Table 5-1. Specific activities (µmol min-1 mg-1) towards PI solubilized in Triton 
X-100 micelles and the ratio of PLCδ1wild type and ∆11 deletion mutant 
activities (errors in values are within 20%).  
 
assay sample WT ∆11 ∆11/WT 
PI/TX-100 (4:8) 9.4 56.6 6.0 
PI/TX-100 (8:16) 18.4 76.2 4.1 
PI/TX-100 (8:32) 11.0 46.4 4.2 
B. Activation effect of non-substrate phospholipids 
The structure of the catalytic domain of PLCδ1 is very similar to the B. 
thuringiensis PI-PLC. The B. thuringiensis PI-PLC is activated by binding to 
zwitterionic surfaces, particularly phosphatidycholine (PC).20 This increases enzyme 
binding to substrate-containing surfaces (bilayers, micelles, etc.) and also appears to 
enhance the catalytic step as well. PLCδ1 could also exhibit activation by other 
phospholipids. The substrate PI(4,5)P2 also binds to the PH domain24 and helps 
anchor the catalytic domain. There are reports that PS also activates the enzyme25, 
although whether or not this anionic lipid affects activity in all assay systems or 
enhances surface binding has not been examined in a systematic fashion. With this in 
mind, we examined the effect of several non-substrate phospholipids (PA, PC, PG, 
PMe, PS) on PLCδ1 cleavage of PI in TX-100 mixed micelles. The concentration of 
enzyme (5 µg/ml for WT and 1 µg/ml for ∆11) and detergent (16 mM TX-100) were 
kept constant. A PI concentration of 8 mM was used as a standard for comparison to 
samples with half of the substrate (4 mM) replaced by non-substrate phospholipids 
(PA, PC, PG, PMe, PS) to determine if the presence of these nonsubstrates alters the 
enzyme specific activity. Because half of the substrate is replaced by non-substrate 
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phospholipids, the activity will decrease if non-substrate phospholipids do not have 
any activation effect. This is because the substrate surface concentration has been 
decreased by a factor of two.  
The specific activities of ∆11 in every condition were higher than those of WT, 
consistent with the X/Y linker acting as an autoinhibitor. For the WT, the activity 
decreased dramatically if half of the substrate was replaced by zwitterionic 
phospholipids (PC). If half of the substrate was replaced by negatively charged 
phospholipids (PA, PG, PMe, PS), the activity was similar to the standard, with 
slightly decreased activity when the PI was replaced by PS and slightly higher activity 
when replaced by PA, PG or PMe. This means that for initial rates, it is the charge of 
the anionic phospholipids that is critical for specific activity. The results for ∆11 were 
similar to those of WT but not exactly the same. Trends are shown in Figure 5-5 
where the activity for each protein is normalized to the value at 8 mM PI. 
For ∆11, the biggest difference was caused by the replacement of PI with PA. 
The negatively charged PA obviously replaced PI in terms of activity for WT enzyme 
(where specific activity towards 8 mM PI and 4 mM PI/4 mM PA were essentially the 
same). However, substitution of half the PI with PA led to a decrease in activity for 
the ∆11 enzyme. Removal of the anionic linker appeared to enhance the inhibitory 
potency of PA selectively. PS was also less effective in replacing PI for ∆11 than for 
WT. These two anionic phospholipids may have a higher affinity for the active site 
than PMe or PG and access is enhanced in ∆11. 
 
 
 Figure 5-5. Relative activities of PI
Triton-X100 micelles (wild type in dark blue and 
concentration of phospholipid was kept at 8 mM with 16 mM detergent.
 
 
C. Binding of PLCδ1 to interface
Previous studies show
play an important role in membrane binding
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the barrel rim that are likely to partition into membranes. T
methods for testing peripheral protein binding to membrane
centrifugation and gel filtration assay
etc.) and NMR methods.26
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1.  PI-PLC activity toward PI in PI/PC LUVs 
The specific activities (µmol min-1 mg-1) of PLCδ1 towards PI/PC mixed LUVs 
are shown in Figure 4-6. The substrate concentration (4 mM) was fixed and the mole 
fraction of PC was gradually increased. When different batches of protein were used 
there was considerable error, but the trends remained. In the pure PI LUVs, WT and 
∆11 showed similar activity towards PI. As the mole fraction of PC, XPC, increased, 
the enzyme activity increased; the activation was highest for WT around XPC=0.25. 
Increasing XPC further led to a decrease in WT PLCδ1 specific activity towards PI. As 
XPC increases with the bulk PI concentration kept constant, the surface concentration 
of PI is decreased and surface dilution inhibition, as detected in the mixed micelle 
system, is seen. Another change is that the surface charge becomes less negative as 
more PC is added to LUVs. The behavior of WT indicates this enzyme is sensitive to 
either the substrate surface concentration or the surface charge or possibly both effects. 
For ∆11 the maximum specific activity was reached at XPC ~ 0.5. At this composition 
of PI/PC, the linker deletion mutant enzyme was ~2.5 times more active than WT at 
the same XPC. PLC specific activity is affected by a wide variety of factors, such as 
overall vesicle binding of the protein, binding of non-substrate lipid in the active site 
or altered lipid dynamics that change the substrate affinity for the vesicle-bound 
protein. Except for pure PI LUVS or when XPC=0.9, the specific activity of ∆11 was 
higher than that of WT with the difference most pronounced in PC-rich vesicles 
(Figure 5-6). These results might suggest that ∆11 binds more tightly to the PC/PI 
mixed vesicles, an explanation that could be tested by measuring protein binding to 
126 
 
PC/anionic substrate analog LUVs.  
 
Figure 5-6. Specific activity of PLCδ1 WT and ∆11 towards PI(4 mM)/PC LUVs as 
a function of mole fraction PC (PC): WT (---♦---) and ∆11(▬■▬). The ratio of 
∆11/WT activities at a given XPC is also shown (…▲…). 
 
 
2.  FRET as a probe of PLCδ1 membrane binding  
Fluorescence resonance energy transfer (FRET) was used to monitor binding of 
PLCδ1 to vesicles. For these experiments, we prepared WT and ∆11 labeled at the 
N-terminus with a fluorescence dye (NBD) to serve as the donor to the rhodamine-PE 
(where the rhodamine dye is attached to the amino group on the phospholipid 
headgroup) in LUVS. Structures of NBD and rhodamine-PE and excitation and 
emission spectra of NBD and rhodamine are show in Figure 5-7. Cysteine is usually 
used for protein labeling, but PLC-δ1 has 25 cysteines in total and more than 10 of them 
are located at the surface of the protein. Thus, the N-terminal amino group of the protein 
was chosen for attachment of the NBD group. The Förster distance (R0), which defines 
the distance when FRET efficiency between the NBD/Rho pair is 50%, is ~56 Å.27 
The crystal structure of PLCδ1 was obtained in two parts – the PH domain was not 
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observed in the structure for full length protein and was crystallized separately. 
Therefore, the relation of the N-terminus of the full length protein to the active site is 
not known. However, since the PH domain can contribute to membrane binding via 
its high affinity for PI(4,5)P2, it most likely does get within R0 to the membrane 
surface. 
The labeled donor, NBD-PLCδ1, was kept at a fixed concentration (typically 0.5 
µM) and vesicles containing the phospholipids PC and PMe with ~ 0.5 mol% Rho-PE 
were titrated into the protein solution. The NBD fluorescence at 535 nm was then 
monitored. PMe was chosen as the PI analog because it is a good inhibitor and should 
have no interaction with the PH domain. When the NBD-protein binds to the vesicle, 
FRET occurs from the NBD group on the protein to the Rho group on the lipids and 
the intensity of the NBD fluorescence decreases. After subtracting the control, which 
is the sum of intensity of NBD-PLCδ1 titrated with unlabeled vesicles and intensity of 
unlabeled PLCδ1 titrated with Rho-labeled vesicles, a dramatic decrease in the 
fluorescence intensity at 535 nm (∆I535) was clearly observed (Figure 5-8). The lines 
through the data shown in Part A of Figure 5-8 represent the best fit assuming a 
simple model for protein binding to the LUVs (a hyperbolic fit was used to extract an 
apparent Kd). The calculated Kd values are summarized in Figure 4-7B. For both WT 
and ∆11, as the fraction of PC increased (from XPC = 0.25 to 0.90), efficient FRET 
required more vesicles added consistent with an increasing Kd, or weaker binding.  
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Figure 5-7. Structures of NBD and rhodamine-PE and excitation and emission 
spectra of NBD and rhodamine: (A) NBD; (B) rhodamine-PE; (C) excitation 
(dashed line) and emission (solid line) spectra of NBD (green) and rhodamine 
(blue). 
(A)  
 
succinimidyl 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoate  NBD-X, SE 
(B)  
 
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) 
(C)  
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Figure 5-8. Titration curves for (A) WT and (B) ∆11 NBD-PLCδ1 binding to 
PC/PMe (0.5 mol% Rho-PE) mixed LUVs at varied XPC: XPC = 0.25 (▬○▬), 
XPC = 0.5 (---□---), XPC = 0.7 (…◊…). The lines through the data represent the 
best fit. In (C) is shown the extracted Kd for partitioning of the proteins to these 
LUVS.  
  
 
(C) 
PLC  Kd (mM)  
 
XPC = 0.25 XPC = 0.5 XPC = 0.7 
WT 0.093±0.008 0.103±0.027 0.388±0.140 
∆11 
0.085±0.009 0.073±0.014 0.306±0.165 
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     All of the data point to the fact that the binding of protein becomes weaker as 
less anionic phospholipid is present. PLCδ1 clearly prefers to bind to a negatively 
charged surface as has been showed in activity studies. ∆11 appears to bind to the 
vesicles slightly more tightly than WT but the differences are small and not 
statistically robust. Thus, removal of the anionic 11-amino acid stretch in the 
XY-linker region does not have a dramatic effect on partitioning of the protein, at 
least at this concentration, onto vesicles.  
3.  PI-PLC binding to vesicles measured by FCS 
FCS (Fluorescence Correlation Spectroscopy) is an experimental technique 
which can monitor protein translational diffusion – a parameter that is dramatically 
affected when a protein binds to a large vesicle.28 The significant advantages of FCS 
are that a low concentration (<1-50 nM) of dye-labeled protein is sufficient for the 
measurement. This concentration range is typically what is used in kinetic assays. We 
used FCS for screening different phospholipid compositions to investigate how 
protein binding was affected by phospholipid compositions.  
For these experiments, PLCδ1 was labeled with AF488 at its N-terminus. This 
Alexa dye has high stability (i.e., does not photobleach readily) and a high quantum 
yield, so is ideal for FCS. In most FCS studies of peptide and protein association with 
vesicles, large unilamellar vesicles (LUVs) were generally used due to their higher 
thermodynamic stability and relatively uniform size.29 The rat PLCδ1 preferentially 
binds to LUVs necessitating the use of LUVs for these binding experiments. LUVs 
composed of different ratios of PC to anionic phospholipids were prepared with a 
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mini-extruder and had an average diameter of 1000 Å as monitored by light 
scattering.30c 
Mutant ∆11 binding to mixed component LUVs 
 From the activity results, we might expect that the composition of the vesicles 
should affect the PLCδ1 binding to the LUVs, although this was not seen in the FRET 
experiments. Since FCS allows us to look at much lower protein concentrations, and 
since it has been suggested the PLCδ1 aggregates at higher concentrations, we felt it 
would be useful to measure vesicle binding using FCS. Therefore, the binding of the 
enzyme to PC/PX (where PX is an anionic phospholipid, either PA, PMe or PS) LUVs. 
The titration curves for AF488 PLCδ1 ∆11 binding to PC/PX vesicles at XPC = 0.5 are 
shown in Figure 5-9. The binding curves were sigmoidal. The fit to these sigmoidal 
curves used the expression fb = fmax*[PL]n / (Kdn+[PL]n), where fb is the fraction 
protein bound, fmax is the maximum fraction bound (usually 0.7-0.9), and n is a 
coefficient to account for the sigmoidal nature of the curve. This n is not the Hill 
coefficient. Rather it is an empirical parameter that accounts for the sigmoidal 
behavior of the profiles. The apparent Kd is the total phospholipid concentration at 
which half the maximum binding of protein is observed. 
In these mixed vesicles, PLCδ1 ∆11 protein had a lower affinity for PA and PS 
(the weakest) compared with PMe. These results are perhaps opposite what one would 
expect from the results of kinetic inhibition using mixed micelles, where PA was the 
most potent inhibitor, followed by PS with little effect by PMe. However. Binding to 
micelles and LUVs can be significantly different. 
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Figure 5-9. Titration curves for AF488-PLCδ1 ∆11 binding to PC/PX (where PX 
is an anionic phospholipid) vesicles at fixed XPC = 0.5. The LUVs contained 
POPC along with POPA (○), DOPMe (□), or DOPS (◊).  
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Figure 5-10. Titration curves for AF488-PLC–δ1 ∆11 binding to PC/PMe vesicles 
as a function of XPC: 0 (○),0.25 (□), 0.5 (◊),0.7 (x) and 0.9 (∆). The lines through 
the data represent the best fit. 
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WT binding to mixed component LUVs 
We performed the same FCS measurements on AF488-labeled WT protein in 
order to test its binding to vesicles containing different anionic phospholipids and to 
PC/PMe mixed LUVs where XPC was varied. The results showed that the enzyme 
binds to the vesicles with lower affinity as PC content increased, but fitting the data 
assuming only two species present – free and vesicle bound protein – was 
problematic.30 When we re-examined the protein-only data, which should have only 
one dye-labeled species present, we found some large particles were present as well as 
a species whose diffusion constant was consistent with a PLC monomer. The protein 
in the FCS experiments (28 nM) is present in buffer (100 mM NaCl, Tris pH 8.0) with 
BSA (1 mg/ml) present to aid in stabilization. We used dimer, trimer, tetramer and so 
on to try to fit two species equation for the protein alone but none of them fit well. At 
the very low protein concentration used in the FCS, most WT exists as monomers but 
there is still some aggregated protein complicating analysis of the data. Interestingly, 
this aggregation problem did not exist with the deletion mutant.  
With LUVs added, we extracted Kd values for labeled WT. Although the 
absolute values are likely not correct given the presence of aggregated protein, the 
trends in terms of how Kd varies with XPC are valid. As shown by the results in Figure 
5-11, at low protein concentration, the apparent Kd of WT is larger than that for ∆11. 
While this difference may not be real, the trend – increased Kd with increasing XPC – 
is similar to the deletion mutant. It is more pronounced for ∆11 in FCS binding 
experiments than in the FRET experiments at considerably higher protein 
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concentrations. This may suggest that protein aggregation (perhaps dimer formation) 
aids in vesicle binding. 
 
Figure 5-11. Dependence of the apparent PI-PLC dissociation constant, Kd, for 
mixed PC/PMe LUVs on XPC: WT (...○...), ∆11(－□－).  The ratio of Kd for WT 
compared to the Kd for ∆11 is also shown (－◊－).  
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destabilize the WT but not ∆11. For example, when XPC equals 0.9, the apparent Kd 
for ∆11 was 881µM; with the same vesicles, WT did not show any appreciable 
binding to the mixed vesicles even when the phospholipids concentration was 
increased to 5 mM. Since assays are done at concentrations more consistent with the 
FCS experiments, it suggests that removal of the XY-linker 11-residue peptide aids in 
stabilizing the form that binds well to vesicles. Furthermore, it strongly suggests that 
the dramatic loss of affinity in the PC-rich region is the reason for the lower specific 
activity observed for ∆11.  
4.  PLC-δ1 activation at constant XPC 
Based on the FCS results, the mutant ∆11 has much lower Kd values than WT in 
the presence of high levels of PC. This difference in affinity for membrane should 
result in different specific activities when the lipid concentration is below or above 
the apparent Kd. Therefore, we compared the catalytic activities of WT and ∆11 at 
XPC = 0.7 with the total phospholipid concentration was equal to 20, 8, or 3 mM. The 
results are shown in Figure 5-12.  
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Figure 5-12. Relative activities of PLC-δ1 enzymes at fixed XPC = 0.7 with 
different concentrations of total phospholipid for WT (filled bars) and ∆11 
(empty bars) enzymes. 
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affinity in the FRET assays likely reflects aggregated protein, which aids in keeping 
the enzyme anchored on the vesicle surface.  
III.  Discussion 
Interfacial activation localized to the PLCδ1 catalytic domain has not been 
reported previously, although mutation of individual hydrophobic residues above the 
barrel rim did lead to reduced catalytic activity31. By measuring the enzyme activity 
towards different types of interfaces, we have tried to determine what factors control 
the catalytic activity of this enzyme. 
∆11, a mutant with 11 negatively charged residues located in the X/Y linker 
region deleted, showed much higher activity than WT. The results obtained with this 
mutant are consistent with the proposed auto-inhibition role for the X/Y linker. 
Anionic phospholipids are critical for the protein to bind to interfaces, and in the 
absence of PI(4,5)P2, the catalytic domain is likely to contribute to anchoring the 
protein to the bilayer. The negatively charged linker peptide could occlude the active 
site and need a strongly negatively charged surface to displace it and allow substrate 
to enter the active site.  
All anionic phospholipids except PA and to a lesser extent PS prevent surface 
dilution inhibition of PI cleavage (Figure 5-5), but only in ∆11 and not WT. PA, with 
the smallest head group, prevents inhibition of WT by supplying the correct negative 
charge, but the activity with ∆11 was decreased, similar to the value for ‘surface 
dilution inhibition’. PA also can have a -2 charge, depending on the surface charge, so 
that it may behave more like a competitive inhibitor of PA than the other anionic 
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phospholipids (see Figure 5-5). PS may also have a slightly higher affinity for the ∆11 
active site, and thus, while it supplies the needed surface charge, it also can occupy 
the active site to some extent. Alternatively for this phospholipid, the pKa of the PS 
amino group many be shifted to a less basic value and the contribution of PS to 
surface charge is less than expected.  
Removing the linker region also allows the protein to bind to vesicles containing 
higher PC content. Even though we cannot obtain an accurate Kd for WT, when XPC 
equals 0.9, ∆11 can bind to PC/PMe mixed vesicles weakly (Kd = 0.88 mM) while 
PLC-δ1 WT does not bind to the vesicles at all.  
FCS experiments with the better behaved ∆11 clearly showed that the enzyme 
binds to the vesicles more weakly as the fraction of PC increased. FRET experiment 
results showed the same trend, although the loss of affinity was not as dramatic as in 
the FRET studies. The WT FCS results are not well fit because of multiple mixed 
forms of protein present in solution. At low protein concentrations, most of the protein 
exists as a monomer and more and more protein becomes aggregated as the 
concentration increases. Removing the linker region may also stabilize the protein 
monomer in solution, suggesting that the aggregation could be related with 
electrostatics of the catalytic domain and the linker region above this αβ-barrel.  
The specific activities in the PLCδ1 assays at constant XPC (Figure 5-12) showed 
differences between WT and ∆11 in the PC-rich region that are consistent with the 
FCS results; the WT Km for substrate in a PC-rich vesicle must be significantly higher 
than that for ∆11 towards the same vesicles since WT activity decreased significantly 
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as the total phospholipid concentration was decreased. One possible explanation is 
that the PLCδ1 exhibits some aggregation at low protein concentration and 
electrostatic interactions of the X/Y linker region modulates this behavior. Increasing 
the protein concentration leads to more aggregation, and in the protein aggregate the 
electrostatic interaction at the X/Y linker region is reduced. Therefore, the apparent Kd 
of WT and ∆11 are almost same in the FRET experiment where much higher protein 
concentrations were used to estimate the apparent Kd values.  
A proposed model for activation of PLC-δ1 is shown in Figure 5-13. PLC-δ1 WT 
exists in mixed forms in solution. At low protein concentration, most of the protein 
exists as monomer but nevertheless there are some aggregated froms. Aggregation in 
solution almost completely disappears after deletion of the eleven negatively charged 
residues in the X/Y linker region to generate ∆11. Thus, ∆11 represents a 
constitutively active enzyme since the active site is not blocked. It is also more prone 
to inhibition by other anionic phospholipids with PA the most effective. PA may 
present an interfacial phosphomonoester similar to PIP2 for binding to the active site. 
The highly negatively charged X/Y linker provides an important control of PLCδ1 
activity on negatively charged membranes such as the inner leaflet of the plasma 
membrane (where the PI(4,5)P2 substrate for the enzyme resides). The negatively 
charged X/Y linkers are sterically and electrostatically repelled from phospholipid 
membranes upon recruitment and orientation of PLCδ1 at these negatively charged 
surfaces. Substrate PI as well as non-substrate anionic phospholipids (PA, PG, PMe, 
PS) can active the enzyme by displacing the X/Y linker. 
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Figure 5-13. Proposed model for activation of PLCδ1: each blue oval represents 
a protein and suggests protein aggregates form from PLCδ1 in dilute solution. 
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 Chapter 6 
Future Directions 
The work in this thesis was directed towards a better understanding of the 
activation mechanism of B. thuringiensis PI-PLC, as well as the kinetic activation and 
inhibition mechanism of the catalytic domain of the multiple-domain peripheral 
membrane protein, rat PI-PLCδ1. The simple single-domain protein was studied as a 
model for the mammalian catalytic domain, mainly because it has a very similar 
3D-stucture and catalytic mechanism to the catalytic domain of PLCδ1, and it is much 
easier to purify. Different approaches were adopted to investigate the interaction 
between these peripheral membrane proteins and phospholipid vesicles composed of 
substrate lipid (or analogues) and/or the kinetic activator phospholipid PC. 
For the B. thuringiensis PI-PLC, the results of the helix B mutant proteins 
provided support for a model for the binding and activation of the enzyme (Figure 
3-8). PI-PLC exists as a monomer in solution and the intact helix B region is 
stabilized by the rigid residue Pro42 that ensures the correct orientation of Lys44 and 
Trp47. Following the initial Lys44-mediated attraction to the anionic membrane, the 
helix B region could lose its structure allowing the substrate PI to bind to the active 
site pocket. During the binding event, several tyrosine residues (including Tyr86 and 
Tyr88) in the rim above the active site contribute to the interaction of the protein with 
PC in bilayers, possibly though π-cation interactions. My results indicate that the 
association of these residues with PC are transient – no long-lived complex is 
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observed with this two residues. Such transient interactions are difficult to follow in 
detail with the binding methods I used. More sensitive techniques, such as FCS, 
which monitors minute spontaneous fluorescence intensity fluctuations rather than 
just the steady-state emission intensity, may provide more details about these 
interactions. For example, FCS could be used to measure the binding of the 
interesting mutant proteins as a function of the mole fraction PC (XPC). In particular, it 
would be useful to have a complete binding profile for hydrophobic rim residue 
mutants including L85A, Y86A, Y86A/Y88A and Y86A/Y88A/Y118A. I showed that 
these proteins had a lower affinity for PC, but it would be useful to assess how 
binding to the PI analog PG and mixed PG./PC bilayers is affected. The dependence 
of Kd on XPC as well as measurement of specific SUV kinetics at different XPC may 
provide useful information on which of these mutations also has defects in substrate 
analog binding in the active site.  
The information on the interaction between the B. thuringiensis PI-PLC and the 
vesicle interface sheds some light on the binding affinity of the catalytic domain of 
mammalian rat PLCδ1. There are several reports on binding affinity of PH domain 
and C2 domain of the enzyme, but we are the first to focus on the study of the 
catalytic domain. The results presented in Chapter 5 of this dissertation showed that 
the linker region between X and Y domains played an auto-inhibition role and 
removal of the linker region rendered high substrate activity of the protein as well as 
er binding to the vesicles under assay conditions. However, WT PLCδ1 aggregation 
proved a serious hurdle in our FCS studies at low protein concentrations, which made 
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the data analysis extremely difficult. Future efforts should focus on identifying a way 
to control this behavior. One possible approach is to make and test a PH domain 
deletion mutant. There are multiple advantages for studying this mutant. First, the PH 
domain plays a role in membrane binding as well (high specificity for PI(4,5)P2) and 
may interfere with the measurement of alterations of the active site. The deletion 
mutant would avoid this complication. Second, the surface charge of the enzyme is 
believed to be an important factor in protein aggregation, and the deletion of the PH 
domain may change that attribute dramatically. 
Another approach is to make and test a different hydrophobic mutant at the loop 
region of the catalytic domain. Preliminary studies along these lines have been carried 
out. The residue Trp555 was chosen because it resides at a very similar position in the 
crystal structure of the enzyme to the position of Trp242 in the B. thuringiensis 
PI-PLC. The results showed that replacement of Trp555 with Ala reduced the cIP 
hydrolysis activity significantly but showed little effect on binding of the protein to 
sphingomyelin and DOPMe single component vesicles through intrinsic fluorescence 
or FRET. To better understand the role of Trp555, more kinetics and binding details 
are needed. For kinetics, one could measure the PI hydrolysis activity in a micelle as 
well as binary (PC/PI) component vesicle system. For measuring the membrane 
protein interaction, a more sensitive assay for quantitative surface binding of 
mammalian PLCδ1 is needed, and FCS or fc-NMR may be such techniques. 
 
 
